<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">xkWLcmv7xtfqVjW4GhjL7qx</article-id>
      <article-id pub-id-type="other">00009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010001300009</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09500309</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010005000084</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fatores de risco cardiovasculares em coorte de profissionais da &#225;rea m&#233;dica: 15 anos de evolu&#231;&#227;o</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jardim</surname>
            <given-names>Thiago de Souza Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jardim</surname>
            <given-names>Paulo C&#233;sar Brand&#227;o Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#250;jo</surname>
            <given-names>Wattusy Estefane Cunha de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jardim</surname>
            <given-names>Luciana Muniz Sanches Siqueira Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salgado</surname>
            <given-names>Claudia Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Goi&#226;nia</named-content>
          <named-content content-type="state">Goi&#225;s</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Goi&#225;s</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>09</month>
        <year>2010</year>
      </pub-date>
      <volume>95</volume>
      <issue>3</issue>
      <fpage>332</fpage>
      <lpage>338</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>08</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>01</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>03</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Segundo a Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS), as doen&#231;as cardiovasculares (DCV) s&#227;o respons&#225;veis por 16,7 milh&#245;es de mortes/ano. Evid&#234;ncias mostram que as DCV resultam da intera&#231;&#227;o entre fatores de risco variados, presentes desde a inf&#226;ncia. OBJETIVO: Verificar, em profissionais da &#225;rea m&#233;dica, a presen&#231;a e evolu&#231;&#227;o de alguns fatores de risco cardiovasculares (FRCV) em um intervalo de 15 anos. M&#201;TODOS: Analisamos um grupo de indiv&#237;duos ao ingressar na faculdade de medicina e repetimos a an&#225;lise 15 anos depois, comparando os dados encontrados. Utilizamos question&#225;rios sobre FRCV (hipertens&#227;o arterial sist&#234;mica (HAS), diabete melito (DM), dislipidemia e hist&#243;ria familiar de DCV precoce, tabagismo, etilismo e sedentarismo). O colesterol, a glicemia, a PA, o peso, a altura, o &#237;ndice de massa corp&#243;rea (IMC) foram determinados. RESULTADOS: Comparamos 100 indiv&#237;duos (sendo 64,0% homens com idade m&#233;dia de 19,9 anos), com os 72 (sendo 62,5% homens, 34,8 anos) inclu&#237;dos 15 anos ap&#243;s. Houve aumento na preval&#234;ncia de HAS (6,0% vs 16,7%, p = 0,024), excesso de peso (9,0% vs 26,4%, p = 0,002) e dislipidemia (4,0% vs 19,14%, p = 0,002). Os demais FRCV n&#227;o se modificaram. Na an&#225;lise dos valores de press&#227;o arterial sist&#243;lica (PAS), press&#227;o arterial diast&#243;lica (PAD), colesterol, glicemia e IMC, encontramos eleva&#231;&#227;o na m&#233;dia de todas vari&#225;veis (p &lt; 0,05). Houve correla&#231;&#227;o positiva entre valores de PAS, PAD, IMC e glicemia no intervalo de tempo avaliado (p &lt; 0,05). CONCLUS&#195;O: Em profissionais da &#225;rea m&#233;dica, encontramos eleva&#231;&#227;o na PAS, PAD, glicemia, IMC e colesterol em 15 anos. Na an&#225;lise da preval&#234;ncia de FRCV, houve aumento de hipertens&#227;o arterial, excesso de peso e dislipidemia.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Fatores de risco</kwd>
        <kwd>pessoal de sa&#250;de</kwd>
        <kwd>estudos transversais</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>09</day>
        <month>07</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGOS ORIGINAIS </p>
    <p> EPIDEMIOLOGIA</p>
    <p>
      <bold>Fatores de risco cardiovasculares em coorte de profissionais da &#225;rea m&#233;dica - 15 anos de evolu&#231;&#227;o</bold>
    </p>
    <p>
      <bold>Thiago de Souza Veiga Jardim; Paulo C&#233;sar Brand&#227;o Veiga Jardim; Wattusy Estefane Cunha de Ara&#250;jo; Luciana Muniz Sanches Siqueira Veiga Jardim; Claudia Maria Salgado</bold>
    </p>
    <p>Universidade Federal de Goi&#225;s, Goi&#226;nia, GO - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="endb">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> Segundo a Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS), as doen&#231;as cardiovasculares (DCV) s&#227;o respons&#225;veis por 16,7 milh&#245;es de mortes/ano. Evid&#234;ncias mostram que as DCV resultam da intera&#231;&#227;o entre fatores de risco variados, presentes desde a inf&#226;ncia. </p>
    <p><bold>OBJETIVO:</bold> Verificar, em profissionais da &#225;rea m&#233;dica, a presen&#231;a e evolu&#231;&#227;o de alguns fatores de risco cardiovasculares (FRCV) em um intervalo de 15 anos. </p>
    <p><bold>M&#201;TODOS:</bold> Analisamos um grupo de indiv&#237;duos ao ingressar na faculdade de medicina e repetimos a an&#225;lise 15 anos depois, comparando os dados encontrados. Utilizamos question&#225;rios sobre FRCV (hipertens&#227;o arterial sist&#234;mica (HAS), diabete melito (DM), dislipidemia e hist&#243;ria familiar de DCV precoce, tabagismo, etilismo e sedentarismo). O colesterol, a glicemia, a PA, o peso, a altura, o &#237;ndice de massa corp&#243;rea (IMC) foram determinados. </p>
    <p><bold>RESULTADOS:</bold> Comparamos 100 indiv&#237;duos (sendo 64,0% homens com idade m&#233;dia de 19,9 anos), com os 72 (sendo 62,5% homens, 34,8 anos) inclu&#237;dos 15 anos ap&#243;s. Houve aumento na preval&#234;ncia de HAS (6,0% <italic>vs</italic> 16,7%, p = 0,024), excesso de peso (9,0% <italic>vs</italic> 26,4%, p = 0,002) e dislipidemia (4,0% <italic>vs</italic> 19,14%, p = 0,002). Os demais FRCV n&#227;o se modificaram. Na an&#225;lise dos valores de press&#227;o arterial sist&#243;lica (PAS), press&#227;o arterial diast&#243;lica (PAD), colesterol, glicemia e IMC, encontramos eleva&#231;&#227;o na m&#233;dia de todas vari&#225;veis (p &lt; 0,05). Houve correla&#231;&#227;o positiva entre valores de PAS, PAD, IMC e glicemia no intervalo de tempo avaliado (p &lt; 0,05). </p>
    <p><bold>CONCLUS&#195;O:</bold> Em profissionais da &#225;rea m&#233;dica, encontramos eleva&#231;&#227;o na PAS, PAD, glicemia, IMC e colesterol em 15 anos. Na an&#225;lise da preval&#234;ncia de FRCV, houve aumento de hipertens&#227;o arterial, excesso de peso e dislipidemia. </p>
    <p><bold>Palavras-chave:</bold> Fatores de risco, pessoal de sa&#250;de/tend&#234;ncias, estudos transversais.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>De acordo com a Organiza&#231;&#227;o Mundial de Sa&#250;de (OMS), as doen&#231;as cardiovasculares (DCV) s&#227;o respons&#225;veis por 16,7 milh&#245;es de mortes por ano. As proje&#231;&#245;es para 2020 mant&#234;m esses agravos como principal causa de morte e incapacita&#231;&#227;o, e, atualmente, as regi&#245;es em desenvolvimento contribuem mais marcadamente para o &#244;nus dessas doen&#231;as do que as regi&#245;es desenvolvidas<sup>1</sup>. No Brasil, estima-se que as DCV respondam por mais de 30,0% dos &#243;bitos em sujeitos a partir dos 20 anos de idade<sup>2</sup>. </p>
    <p>A literatura apresenta claras evid&#234;ncias de que as DCV manifestas na idade adulta resultam de uma complexa intera&#231;&#227;o entre fatores de risco variados presentes desde a inf&#226;ncia e adolesc&#234;ncia<sup>3</sup>.</p>
    <p>Grande parte desses conhecimentos acerca dos fatores de risco cardiovasculares (FRCV) adv&#233;m do consagrado estudo de Framingham<sup>4</sup>. Trata-se de uma das primeiras coortes onde foi demonstrada a import&#226;ncia de alguns fatores de risco para o desenvolvimento de doen&#231;as card&#237;acas e cerebrovasculares. Em 2004, Yusuf e cols. publicaram o estudo INTERHEART<sup>5</sup>, que foi uma investiga&#231;&#227;o de caso-controle internacional, delineada para avaliar de forma sistematizada a import&#226;ncia de fatores de risco para doen&#231;a arterial coronariana ao redor do mundo. Nessa avalia&#231;&#227;o, 9 fatores de risco explicaram mais de 90,0% do risco atribu&#237;vel para IAM. Embora com algumas diferen&#231;as regionais, esses dados contempor&#226;neos confirmaram os fatores de risco tradicionais, previamente estabelecidos<sup>5</sup>.</p>
    <p>Os dados referentes aos FRCV s&#227;o escassos na Am&#233;rica Latina<sup>6</sup>. No Brasil, a situa&#231;&#227;o n&#227;o &#233; diferente. Isto ocorre tanto no que se refere &#224; incid&#234;ncia e quanto &#224; preval&#234;ncia, mas especialmente com rela&#231;&#227;o &#224; avalia&#231;&#227;o evolutiva destes FRCV na popula&#231;&#227;o<sup>7-12</sup>.</p>
    <p>O conhecimento sobre os FRCV, a presen&#231;a destes fatores em popula&#231;&#245;es de baixa idade, sua evolu&#231;&#227;o ao longo do tempo, assim como a avalia&#231;&#227;o de comportamentos de risco, podem contribuir de maneira significativa para a&#231;&#245;es que modifiquem a hist&#243;ria natural destes riscos, permitindo a preven&#231;&#227;o do aparecimento das doen&#231;as cardiovasculares<sup>11-13</sup>. </p>
    <p>Com este objetivo, estudamos em uma popula&#231;&#227;o, que inicialmente era de estudantes de medicina, e no momento seguinte, era constitu&#237;da por profissionais da &#225;rea m&#233;dica, a presen&#231;a e a evolu&#231;&#227;o dos fatores de risco cardiovasculares em um intervalo de 15 anos. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>O projeto de pesquisa foi avaliado e aprovado pelo Comit&#234; de &#201;tica em Pesquisa M&#233;dica Humana e Animal do Hospital das Cl&#237;nicas da Faculdade de Medicina da Universidade Federal de Goi&#225;s.</p>
    <p>Trata-se de um estudo de coorte hist&#243;rica, em que a popula&#231;&#227;o estudada foi composta por acad&#234;micos da Faculdade de Medicina da Universidade Federal de Goi&#225;s que iniciaram o curso no ano de 1993. Os mesmos indiv&#237;duos foram reavaliados ap&#243;s 15 anos, j&#225; como profissionais dentro das diversas especialidades m&#233;dicas. Sendo assim, o estudo foi desenvolvido em duas etapas.</p>
    <p>Foram exclu&#237;dos aqueles que n&#227;o concordaram em participar em qualquer etapa do estudo, os portadores de cardiopatia cong&#234;nita, de diabete melito tipo 1, e aqueles que n&#227;o estavam inscritos no Conselho Regional de Medicina, &#224; &#233;poca da segunda etapa do estudo.</p>
    <p>Na primeira fase, os sujeitos da pesquisa foram selecionados em datas pr&#233;-determinadas agendadas com a dire&#231;&#227;o da faculdade, e, na segunda fase, foram localizados atrav&#233;s do Conselho Regional de Medicina de Goi&#225;s, por contato telef&#244;nico e posterior agendamento de entrevista para coleta de dados. Para indiv&#237;duos que n&#227;o residiam na grande Goi&#226;nia, essa coleta foi realizada por telefone. Os dados referidos, nesses casos espec&#237;ficos, foram considerados para an&#225;lise final. Todos os participantes foram informados sobre os procedimentos do estudo em 1993 e assinaram um termo de consentimento livre e esclarecido, sendo o mesmo procedimento repetido na etapa posterior.</p>
    <p>O question&#225;rio utilizado em 1993 foi novamente aplicado ap&#243;s 15 anos, sendo as mesmas vari&#225;veis interrogadas. Foram elas: idade, sexo, diagn&#243;stico e tratamento pr&#233;vio de hipertens&#227;o arterial sist&#234;mica, dislipidemia ou diabete. Os indiv&#237;duos foram questionados ainda sobre a ocorr&#234;ncia de evento cardiovascular maior (infarto agudo do mioc&#225;rdio - IAM, acidente vascular cerebral - AVC, ou necessidade de revasculariza&#231;&#227;o do mioc&#225;rdio - RVM). </p>
    <p>Quanto aos h&#225;bitos de vida, foi analisado o hist&#243;rico de tabagismo (fumante ou n&#227;o fumante), etilismo (ingest&#227;o de bebida alco&#243;lica ou n&#227;o) e pr&#225;tica de atividade f&#237;sica (sedent&#225;rio - sem qualquer atividade f&#237;sica, atividade f&#237;sica irregular - quando menos de 30 minutos por tr&#234;s vezes/semana e regular - quando maior ou igual a 30 minutos tr&#234;s vezes/semana). A presen&#231;a de doen&#231;a cardiovascular precoce em familiar de primeiro grau (&lt; 65 anos para mulheres e &lt; 55 anos para homens) tamb&#233;m foi considerada.</p>
    <p>
      <bold>Medidas objetivas</bold>
    </p>
    <p>Na primeira e segunda etapas, as seguintes vari&#225;veis foram avaliadas com as mesmas metodologias do estudo:</p>
    <p><italic>Peso - </italic>indiv&#237;duos vestidos com roupas leves e sem cal&#231;ados, com utiliza&#231;&#227;o de balan&#231;a eletr&#244;nica da marca Plenna Lithium, com capacidade m&#225;xima de 150 kg e precis&#227;o de 100 g.</p>
    <p><italic>Altura - </italic>indiv&#237;duos descal&#231;os, utilizando estadi&#244;metro SECCA a laser, modelo 206, com precis&#227;o de 0,1 cm.</p>
    <p><italic>&#205;ndice de massa corp&#243;rea (IMC) -</italic> atrav&#233;s da f&#243;rmula estabelecida por Quetelet (IMC = peso em kg/altura<sup>2 </sup>em metro)<sup>14</sup>. Valores de IMC <underline>&gt;</underline> 25 kg/m<sup>2 </sup>foram considerados como excesso de peso<sup>15</sup>. </p>
    <p><italic>Press&#227;o arterial (PA) - </italic>aparelhos semiautom&#225;ticos da marca OMRON HEM705 CP aferidos foram utilizados. As medidas foram realizadas ap&#243;s 5 minutos de repouso, no membro superior direito, com o indiv&#237;duo na posi&#231;&#227;o sentada e com o bra&#231;o apoiado. Foram realizadas duas medidas, com intervalo de dois minutos. Para fins de an&#225;lise dos dados, foi considerada a segunda medida da press&#227;o arterial, tendo a hipertens&#227;o arterial definida por valores maiores ou iguais &#224; 140/90 mmHg<sup>16</sup>. </p>
    <p><italic>Circunfer&#234;ncia da cintura (CC) - </italic>aferida apenas na segunda etapa do estudo (no ponto m&#233;dio entre a &#250;ltima costela e a crista il&#237;aca ao final da expira&#231;&#227;o), com fita m&#233;trica graduada em cent&#237;metros. Considerada aumentada se maior de 88 cm para mulheres e maior de 102 cm para homens<sup>15</sup>. </p>
    <p>
      <bold>Dados colhidos por telefone</bold>
    </p>
    <p>A coleta de dados por telefone foi realizada com 11 indiv&#237;duos. Nesses casos, foram utilizados o peso e a altura referidos. Aos mesmos, foram solicitadas a aferi&#231;&#227;o da press&#227;o arterial com aparelho calibrado utilizado na pr&#225;tica di&#225;ria do m&#233;dico e a medida da circunfer&#234;ncia da cintura, seguindo as recomenda&#231;&#245;es previstas no estudo. Por se tratarem de profissionais da sa&#250;de, n&#227;o houve dificuldades para a execu&#231;&#227;o de tais procedimentos e os dados foram considerados confi&#225;veis.</p>
    <p>
      <bold>Dados laboratoriais</bold>
    </p>
    <p>Na primeira etapa, ap&#243;s 12 horas de jejum, a dosagem da glicemia e colesterol foi realizada em amostra de sangue colhida atrav&#233;s de pun&#231;&#227;o digital com lanceta, e a leitura realizada atrav&#233;s de m&#233;todo de fita utilizando os aparelhos de HEMOGLUCOTEST e o REFLOTRON, respectivamente.</p>
    <p>Para a segunda etapa, foram utilizados os exames de glicemia de jejum e perfil lip&#237;dico, realizados at&#233; 6 meses antes do preenchimento do question&#225;rio, desde que colhidos ap&#243;s 12 horas de jejum e seguindo a recomenda&#231;&#227;o da n&#227;o ingest&#227;o de bebida alco&#243;lica por 48 h, antecedendo a coleta. Apenas 5 indiv&#237;duos n&#227;o possu&#237;am os resultados dos exames necess&#225;rios que se enquadrassem nesses requisitos, sendo que nestes foi realizada nova coleta. O m&#233;todo utilizado para dosagem do colesterol total (CT), HDL colesterol (HDL), triglic&#233;rides s&#233;ricos (TG) e da glicemia plasm&#225;tica foi o colorim&#233;trico-enzim&#225;tico para todos os sujeitos inclu&#237;dos na an&#225;lise, mesmo que a coleta n&#227;o tenha sido realizada no mesmo laborat&#243;rio. O valor do LDL colesterol foi estimado pela f&#243;rmula de Friedewald, onde LDL = CT - (HDL+ TG/5)<sup>17</sup>.</p>
    <p>Foram considerados como dislipid&#234;micos aqueles que possu&#237;am valores de colesterol total iguais ou acima de 200 mg/dl. Optou-se por n&#227;o utilizar as fra&#231;&#245;es do colesterol e o triglic&#233;rides nesta avalia&#231;&#227;o, pois estes dados n&#227;o eixstiam na an&#225;lise inicial da amostra, impossibilitando assim a compara&#231;&#227;o. </p>
    <p>Apesar de a metodologia empregada para dosagem de colesterol e glicemia n&#227;o ser a mesma nas duas etapas do estudo, j&#225; existe na literatura uma ampla documenta&#231;&#227;o em rela&#231;&#227;o &#224; correla&#231;&#227;o entre os valores obtidos por estes m&#233;todos, n&#227;o havendo com isso preju&#237;zo na an&#225;lise dos dados<sup>18-21</sup>. </p>
    <p>
      <bold>Banco de dados e an&#225;lise de estat&#237;stica</bold>
    </p>
    <p>Os dados foram armazenados em banco de dados pr&#243;prio, estruturado no programa Excel (Microsoft) e analisados comparativamente. A an&#225;lise estat&#237;stica foi realizada atrav&#233;s do <italic>software SPSS</italic> (<italic>Statistical Package of Social Science</italic>, vers&#227;o 15.0, Chicago, IL, USA). O teste de Kolmogorov-Smirnov foi utilizado para analisar se as vari&#225;veis cont&#237;nuas apresentavam distribui&#231;&#227;o normal. O teste <italic>t</italic> de <italic>Student</italic> para amostras pareadas foi usado para comparar as vari&#225;veis num&#233;ricas do estudo, expressas em m&#233;dia e desvio-padr&#227;o. A an&#225;lise comparativa dos FRCV entre 1993-2008 foi realizada utilizando o teste do qui-quadrado e o teste de Fisher. A an&#225;lise da correla&#231;&#227;o das vari&#225;veis num&#233;ricas entre as duas etapas do estudo foi realizada pelo teste de correla&#231;&#227;o de Pearson. Foram considerados significantes valores de p &lt; 0,05.</p>
    <p>
      <bold>Financiamento</bold>
    </p>
    <p>O presente estudo foi parcialmente financiado com recursos da Bolsa de aux&#237;lio &#224; Pesquisa da Sociedade Brasileira de Cardiologia (SBC). </p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>O banco de dados da primeira etapa do estudo foi composto por 100 indiv&#237;duos, dos quais, ap&#243;s 15 anos, 74 (74,0%) foram localizados para a segunda fase da an&#225;lise. Foram exclu&#237;dos dois indiv&#237;duos, um por n&#227;o concordar em participar e um outro por ter sido diagnosticado, nesse intervalo, como diab&#233;tico tipo 1, sendo os dados de 72 m&#233;dicos utilizados para a an&#225;lise dos dados.</p>
    <p>Dos 100 indiv&#237;duos estudados em 1993, 39,0% eram do sexo feminino, com idade m&#233;dia de 19,9 anos (m&#237;nimo de 18 e m&#225;ximo de 22 anos). No grupo estudado em 2008, a idade m&#233;dia foi de 34,8 anos (m&#237;nimo 33 e m&#225;ximo 37), com 37,5% destes sendo do sexo feminino. </p>
    <p>Na primeira etapa do trabalho, nenhum dos acad&#234;micos de medicina afirmou ser portador de hipertens&#227;o arterial, dislipidemia ou diabete. J&#225; na segunda an&#225;lise, em rela&#231;&#227;o ao conhecimento sobre hipertens&#227;o arterial, um indiv&#237;duo afirmou ser hipertenso e estar sob tratamento. Para dislipidemia, esse n&#250;mero foi maior, com 6 sujeitos afirmando serem portadores de desvio do perfil lip&#237;dico, e que apenas tr&#234;s (50%) estavam sob tratamento (farmacol&#243;gico ou n&#227;o). N&#227;o houve refer&#234;ncia ao conhecimento sobre diabete tipo 2. </p>
    <p>N&#227;o foram descritos eventos cardiovasculares precoces em familiares de primeiro grau em 1993, sendo referidos eventos por 15 indiv&#237;duos em 2008. </p>
    <p>Nenhum evento cardiovascular ocorreu no grupo avaliado ap&#243;s 15 anos de evolu&#231;&#227;o.</p>
    <p>Na an&#225;lise das preval&#234;ncias dos fatores de risco cardiovasculares na popula&#231;&#227;o estudada entre 1993-2008, houve um aumento significativo de hipertens&#227;o arterial sist&#234;mica, excesso de peso e dislipidemia. Para os demais FRCV (sedentarismo, tabagismo e etilismo), as altera&#231;&#245;es n&#227;o foram significativas (<xref ref-type="table" rid="tab1">Tabela 1</xref>).</p>
    <table-wrap id="tab1">
      <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt01.jpg"/></table-wrap>
    <p>A compara&#231;&#227;o dos valores de press&#227;o arterial sist&#243;lica (PAS), press&#227;o arterial diast&#243;lica (PAD), IMC, glicemia e colesterol nos dois momentos mostrou eleva&#231;&#227;o dos valores m&#233;dios com diferen&#231;a significativa em todas as vari&#225;veis (<xref ref-type="table" rid="tab2">Tabela 2</xref>).</p>
    <table-wrap id="tab2">
      <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt02.jpg"/></table-wrap>
    <p>Ao avaliarmos as mesmas vari&#225;veis por sexo, verificamos que no sexo masculino h&#225; eleva&#231;&#227;o significativa em todas as vari&#225;veis (press&#227;o sist&#243;lica e diast&#243;lica, IMC, glicemia e colesterol), enquanto que no sexo feminino h&#225; eleva&#231;&#227;o significativa apenas no IMC, glicemia e colesterol (<xref ref-type="table" rid="tab3">Tabelas 3</xref> e <xref ref-type="table" rid="tab4">4</xref>).</p>
    <table-wrap id="tab3">
      <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt03.jpg"/></table-wrap>
    <table-wrap id="tab4">
      <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt04.jpg"/></table-wrap>
    <p>N&#227;o houve diferen&#231;a entre a preval&#234;ncia dos FRCV, ao avaliarmos cada um dos sexos separadamente, exce&#231;&#227;o feita ao excesso de peso. Nessa vari&#225;vel, entre os homens, encontramos 6 (13,33%) indiv&#237;duos com IMC <underline>&gt;</underline> 25 kg/m<sup>2</sup> em 1993, enquanto que, em 2008, j&#225; eram 14 (31,1%) jovens com esta classifica&#231;&#227;o de IMC (p &lt; 0,001).</p>
    <p>Na an&#225;lise de correla&#231;&#227;o entre os valores obtidos em 1993 e 2008, verificamos correla&#231;&#227;o positiva entre valores de press&#227;o arterial sist&#243;lica, diast&#243;lica, IMC e glicemia (p &lt; 0,001). Para o colesterol, tal correla&#231;&#227;o n&#227;o foi demonstrada (r = 0,186, p = 0,117;) (<xref ref-type="fig" rid="aop08210a03fig01m">Figura 1</xref>).</p>
    <p content-type="asset">
      <fig id="aop08210a03fig01m">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gf01.jpg"/></fig>
    </p>
    <p>A circunfer&#234;ncia da cintura foi avaliada apenas na segunda etapa do trabalho, impossibilitando a compara&#231;&#227;o. Foram encontrados 9 (12,5%) indiv&#237;duos com aumento da CC, sendo tr&#234;s mulheres e 6 homens.</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Este estudo detectou um aumento significativo na preval&#234;ncia de alguns fatores de risco cardiovasculares (excesso de peso, dislipidemia e hipertens&#227;o arterial sist&#234;mica) na popula&#231;&#227;o estudada. Estes achados n&#227;o se repetiram nos outros fatores de risco cardiovasculares analisados. Tabagismo, sedentarismo e etilismo foram aspectos comportamentais que n&#227;o se alteraram de forma significativa ao longo do per&#237;odo avaliado. </p>
    <p>O aumento da preval&#234;ncia e do excesso de peso ao longo do tempo j&#225; foi detectado por alguns estudos brasileiros, entre eles os estudos de Ciorlia e Lotufo, com an&#225;lises de evolu&#231;&#227;o do IMC em popula&#231;&#245;es espec&#237;ficas<sup>9,22</sup>. Al&#233;m disso, a epidemia de obesidade j&#225; &#233; uma realidade em pa&#237;ses desenvolvidos, e tamb&#233;m vem sendo observado nos pa&#237;ses em desenvolvimento<sup>23,24</sup>. O nosso grupo de estudo, mesmo sendo diferenciado por sua educa&#231;&#227;o formal na &#225;rea de sa&#250;de, n&#227;o apresentou evolu&#231;&#227;o diferente. Ainda assim, as preval&#234;ncias de excesso de peso foram menores nos dois momentos da an&#225;lise, quando comparadas com as da popula&#231;&#227;o de capitais brasileiras nas mesmas faixas et&#225;rias<sup>25</sup>.</p>
    <p>A preval&#234;ncia da dislipidemia, mesmo tendo se elevado de forma significativa ao longo do estudo, foi muito inferior aos dados da literatura produzida no Brasil, nos dois momentos da avalia&#231;&#227;o. Levantamentos de indiv&#237;duos, de 9 capitais, com idade m&#233;dia de 35,4 anos, nesse aspecto bastante semelhante &#224; popula&#231;&#227;o da segunda etapa da nossa an&#225;lise, indicam preval&#234;ncia de colesterol total <underline>&gt;</underline> 200 mg/dl de 38,0% para o sexo masculino e 42,0% para o feminino<sup>26</sup>. Nossos dados mostraram apenas 19,4% para ambos os sexos. </p>
    <p>Ao compararmos o n&#250;mero de indiv&#237;duos hipertensos, no grupo por n&#243;s estudado nos dois momentos, com a popula&#231;&#227;o de Goi&#226;nia<sup>27</sup> dividida por faixa et&#225;ria, encontramos menores &#237;ndices de HAS em nosso grupo nos dois per&#237;odos, apesar da detec&#231;&#227;o do aumento da preval&#234;ncia de HAS, ao longo dos 15 anos. Essas informa&#231;&#245;es corroboram a rela&#231;&#227;o entre hipertens&#227;o arterial e baixos n&#237;veis de escolaridade, uma vez que a popula&#231;&#227;o do nosso estudo &#233; composta, no primeiro momento, por universit&#225;rios, e, no segundo momento, por profissionais com curso superior completo, portanto, com maior grau de instru&#231;&#227;o quando comparada &#224; popula&#231;&#227;o geral de Goi&#226;nia. </p>
    <p>Nosso estudo demonstrou que mesmo entre os fatores de risco cardiovasculares que aumentaram sua preval&#234;ncia de forma significativa ao longo dos 15 anos de seguimento, estas preval&#234;ncias foram menores do que na popula&#231;&#227;o geral. Esses dados s&#227;o superpon&#237;veis aos encontrados no <italic>Physicians Health Study</italic><sup>28</sup>, onde demonstrou-se uma preval&#234;ncia de fatores de risco cardiovasculares substancialmente menor entre os m&#233;dicos americanos quando comparados &#224; popula&#231;&#227;o geral. </p>
    <p>Dados de um inqu&#233;rito domiciliar do Minist&#233;rio da Sa&#250;de revelaram preval&#234;ncia de tabagismo variando de 12,9-25,2%, dependendo da cidade analisada, com aumento desta preval&#234;ncia em indiv&#237;duos com menor grau de escolaridade e de maiores faixas et&#225;rias<sup>25</sup>. Levando-se em considera&#231;&#227;o as preval&#234;ncias de 1,0% e 5,6% nos dois momentos da nossa pesquisa, conclu&#237;mos que os profissionais de sa&#250;de analisados neste estudo fumam menos do que a popula&#231;&#227;o geral, obedecendo ao mesmo padr&#227;o de distribui&#231;&#227;o por idade da popula&#231;&#227;o das capitais brasileiras. </p>
    <p>No grupo que investigamos, o sedentarismo foi identificado em 35,0% na primeira fase e 27,8% na segunda, mas esta redu&#231;&#227;o n&#227;o teve signific&#226;ncia estat&#237;stica. Na popula&#231;&#227;o de 9 capitais brasileiras, esse fator de risco para doen&#231;as cardiovasculares variou de 28,2% a 54,5%, entretanto, diferentemente do que encontramos, a popula&#231;&#227;o tendeu a ser mais ativa entre os 15 a 24 anos. Outro dado interessante &#233; a aus&#234;ncia da influ&#234;ncia do grau de escolaridade sobre a preval&#234;ncia de sedentarismo<sup>25</sup>, dados que confirmam os nossos achados.</p>
    <p>O consumo de &#225;lcool n&#227;o apresentou varia&#231;&#227;o significativa, com preval&#234;ncias nos dois momentos estudados semelhantes &#224;s da popula&#231;&#227;o de capitais brasileiras. Devemos destacar que a tend&#234;ncia ao aumento do consumo de bebidas alco&#243;licas com o aumento da idade e do grau de escolaridade<sup>25</sup> n&#227;o foi encontrada em nosso estudo.</p>
    <p>Separando a evolu&#231;&#227;o das preval&#234;ncias dos fatores de risco por sexo, entre os dois momentos, encontramos diferen&#231;a apenas no excesso de peso, sendo maior no sexo masculino. Todos os demais FRCV, quando analisados por sexo, n&#227;o se modificaram ao longo dos anos. Tal fato sugere que, nesse grupo de indiv&#237;duos, a evolu&#231;&#227;o dessas preval&#234;ncias ocorre de forma homog&#234;nea entre os dois sexos, exce&#231;&#227;o feita ao excesso de peso. Entretanto, a amostra n&#227;o foi grande o suficiente para demonstrar com seguran&#231;a diferen&#231;as na evolu&#231;&#227;o entre os sexos. </p>
    <p>Na an&#225;lise num&#233;rica dos n&#237;veis de press&#227;o, valores de colesterol, glicemia e IMC, ficou demonstrada a eleva&#231;&#227;o significativa em todas estas vari&#225;veis ao longo dos 15 anos, talvez pelo pr&#243;prio envelhecimento da popula&#231;&#227;o estudada. Observando essas mesmas vari&#225;veis por sexo. Detectamos aumento significativo de IMC, glicemia e colesterol em ambos os sexos, enquanto que para a press&#227;o arterial (sist&#243;lica e diast&#243;lica) o aumento s&#243; foi significativo para o sexo masculino.</p>
    <p>No estudo da correla&#231;&#227;o entre os valores obtidos em 1993 com os de 2008, encontramos uma n&#237;tida correla&#231;&#227;o positiva entre PAD, PAS, glicemia e IMC, ou seja, os mesmos indiv&#237;duos que apresentavam n&#237;veis mais altos em 1993, apresentaram-nos em 2008. J&#225; os valores de colesterol n&#227;o se correlacionaram entre os dois momentos do estudo. Em uma an&#225;lise mais detalhada desses dados, foi observada maior correla&#231;&#227;o (valores de r maiores) para a press&#227;o arterial sist&#243;lica e &#237;ndice de massa corp&#243;rea, sugerindo que a monitoriza&#231;&#227;o e a abordagem mais agressiva sobre o controle destas vari&#225;veis poderiam ter maior impacto como medidas de promo&#231;&#227;o de sa&#250;de, apesar dos valores de <italic>p</italic> terem mostrado resultados significativos em rela&#231;&#227;o &#224; compara&#231;&#227;o de todas as vari&#225;veis acima consideradas. </p>
    <p>Conforme j&#225; sugeriram Monego e Jardim, ao estudarem os determinantes de risco para doen&#231;as cardiovasculares em escolares<sup>29</sup>, estes dados podem ser utilizados em estrat&#233;gias de interven&#231;&#227;o precoce sobre fatores de risco modific&#225;veis. </p>
    <p>Algumas limita&#231;&#245;es do nosso trabalho devem ser mencionadas. Uma delas reside no fato da n&#227;o localiza&#231;&#227;o, em 2008, de todos os indiv&#237;duos avaliados em 1993. Isto se justifica pelo longo intervalo de tempo entre as duas coletas de dados, sendo que neste per&#237;odo n&#227;o foi mantido nenhum contato com esses sujeitos da pesquisa. Apesar disto, a reavalia&#231;&#227;o de mais de 70% dos indiv&#237;duos do grupo inicial torna a amostra representativa e permite as conclus&#245;es apresentadas.</p>
    <p>As amostras de glicemia e perfil lip&#237;dico na segunda avalia&#231;&#227;o tamb&#233;m merecem men&#231;&#227;o. Essas amostras foram obtidas em laborat&#243;rios diferentes e, em uma parte desses m&#233;dicos (11 indiv&#237;duos, 15,27% da amostra estudada na segunda avalia&#231;&#227;o), os resultados foram obtidos por via telef&#244;nica. Um dado a ser destacado &#233; que a metodologia empregada na an&#225;lise das vari&#225;veis bioqu&#237;micas foi a mesma (colorim&#233;trico-enzim&#225;tico), independente da varia&#231;&#227;o do laborat&#243;rio ou da coleta ter sido realizada por via telef&#244;nica. Salienta-se ainda a qualidade das informa&#231;&#245;es colhidas por via telef&#244;nica, j&#225; que se tratavam de profissionais m&#233;dicos.</p>
    <p>Outra limita&#231;&#227;o a ser observada foi a utiliza&#231;&#227;o, nas duas etapas da investiga&#231;&#227;o, de metodologias diferentes para an&#225;lise do colesterol e glicemia. Apesar da metodologia empregada n&#227;o ter sido a mesma, j&#225; existe na literatura uma ampla documenta&#231;&#227;o que confirma a correla&#231;&#227;o entre os valores obtidos por tais m&#233;todos, n&#227;o havendo com isso preju&#237;zo na an&#225;lise dos dados<sup>18-21</sup>. Al&#233;m disso, a an&#225;lise do perfil lip&#237;dico e da glicemia s&#233;rica amplia as possibilidades de abordagens futuras dessa popula&#231;&#227;o no que diz respeito a esses fatores, que s&#227;o importantes determinantes de risco cardiovascular. </p>
    <p>
      <bold>Conclus&#245;es</bold>
    </p>
    <p>Em uma coorte de profissionais da &#225;rea m&#233;dica, houve eleva&#231;&#227;o na PAS, PAD, glicemia, IMC e colesterol, em 15 anos de evolu&#231;&#227;o. Na an&#225;lise da preval&#234;ncia de fatores de risco cardiovascular, observou-se aumento da preval&#234;ncia de hipertens&#227;o arterial sist&#234;mica, excesso de peso e dislipidemia. </p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi parcialmente financiado pela Bolsa de aux&#237;lio &#224; Pesquisa da Sociedade Brasileira de Cardiologia.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Thiago de Souza Veiga Jardim pela Universidade Federal de Goi&#225;s.</p>
    <p>
      <fn id="endb" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Thiago de Souza Veiga Jardim </p>
        <p> Rua 54 n. 450/503A - Edf. Al Mar&#233; - Jardim Goi&#225;s </p>
        <p> 74810-220 - Goi&#226;nia, GO - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="thiagoveiga@cardiol.br">thiagoveiga@cardiol.br</email>, </p>
        <p>
          <email xlink:href="thiagoloirin@hotmail.com">thiagoloirin@hotmail.com</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 22/08/09; revisado recebido em 27/01/10; aceito em 11/03/10.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Ramires JAF, Chagas ACP, Panorama das doen&#231;as cardiovasculares no Brasil. In: Nobre F, Serrano CV, editores. Tratado de cardiologia SOCESP. S&#227;o Paulo: Manole; 2005 .p. 7-46.</mixed-citation>
        <element-citation publication-type="book">
          <source>Tratado de cardiologia SOCESP</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>7</fpage>
          <lpage>46</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Ramires</surname>
              <given-names>JAF</given-names>
            </name>
            <name>
              <surname>Chagas</surname>
              <given-names>ACP</given-names>
            </name>
            <name>
              <surname>Nobre</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Serrano</surname>
              <given-names>CV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2.	Minist&#233;rio da Sa&#250;de. Datasus. [Acesso em 2009 jun 12]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.datasus.gov.br/datasus/datasus.php">http://www.datasus.gov.br/datasus/datasus.php</ext-link></mixed-citation>
        <element-citation publication-type="webpage">
          <comment>Available at:<ext-link ext-link-type="uri" xlink:href="http://http://www.datasus.gov.br/datasus/datasus.php">link</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Berenson GS, Srinavasan SR, Hunter SM, Nicklas TA, Freedman DS, Shear CL, et al. Risk factors in early life as predictors of adult heart disease: The Bogalusa Heart Study. Am J Med Sci. 1989; 298 (3): 141-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Risk factors in early life as predictors of adult heart disease: The Bogalusa Heart Study</article-title>
          <source>Am J Med Sci</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>141</fpage>
          <lpage>51</lpage>
          <issue>3</issue>
          <volume>298</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Berenson</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Srinavasan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Nicklas</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Shear</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Framingham Heart Study. Profile of the Framingham Heart Study. [Acesso em 2009 jun 12]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.framingham.com/heart/profile.htm">http://www.framingham.com/heart/profile.htm</ext-link></mixed-citation>
        <element-citation publication-type="book">
          <source>Profile of the Framingham Heart Study</source>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Yusuf SHawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTREHEART study investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (The INTERHEART study): case control study. Lancet. 2004; 364 (9438): 937-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>INTREHEART study investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (The INTERHEART study): case control study</article-title>
          <source>Lancet</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>937</fpage>
          <lpage>52</lpage>
          <issue>9438</issue>
          <volume>364</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yusuf SHawken</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ounpuu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dans</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Avezum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lanas</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Girotto CA, Vacchino MN, Spillmann CA, Soria JA. Prevalence of cardiovascular risk factors in first year university students. Rev Saude Publica. 1996; 30 (6): 576-86.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of cardiovascular risk factors in first year university students</article-title>
          <source>Rev Saude Publica</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>576</fpage>
          <lpage>86</lpage>
          <issue>6</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Girotto</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Vacchino</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Spillmann</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Soria</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Avezum A, Piegas LS, Pereira JC. Fatores de risco associados com infarto agudo do mioc&#225;rdio na regi&#227;o metropolitana de S&#227;o Paulo: uma regi&#227;o desenvolvida em um pa&#237;s em desenvolvimento. Arq Bras Cardiol. 2005; 84 (3): 206-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fatores de risco associados com infarto agudo do mioc&#225;rdio na regi&#227;o metropolitana de S&#227;o Paulo: uma regi&#227;o desenvolvida em um pa&#237;s em desenvolvimento</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>206</fpage>
          <lpage>13</lpage>
          <issue>3</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Avezum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Piegas</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Piegas LS, Avezum A, Pereira JC, Neto JM, Hoepfner C, Farran JA, et al. AFIRMAR study investigators. Risk factors for myocardial infarction in Brazil. Am Heart J. 2003; 146 (2): 331-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>AFIRMAR study investigators: Risk factors for myocardial infarction in Brazil</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>331</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>146</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Piegas</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Avezum</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hoepfner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Farran</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Ciorlia LAS, Godoy MF. Fatores de risco cardiovascular e mortalidade: seguimento em longo prazo (at&#233; 20 anos) em programa preventivo realizado pela medicina ocupacional. Arq Bras Cardiol. 2005; 85 (1): 20-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fatores de risco cardiovascular e mortalidade: seguimento em longo prazo (at&#233; 20 anos) em programa preventivo realizado pela medicina ocupacional</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>20</fpage>
          <lpage>5</lpage>
          <issue>1</issue>
          <volume>85</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ciorlia</surname>
              <given-names>LAS</given-names>
            </name>
            <name>
              <surname>Godoy</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Coelho VG, Caetano LF, Liberatore Junior RR, Cordeiro JA, Souza DR. Perfil lip&#237;dico e fatores de risco para doen&#231;as cardiovasculares em estudantes de medicina. Arq Bras Cardiol. 2005; 85 (1): 57-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Perfil lip&#237;dico e fatores de risco para doen&#231;as cardiovasculares em estudantes de medicina</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>57</fpage>
          <lpage>62</lpage>
          <issue>1</issue>
          <volume>85</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Coelho</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Caetano</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Liberatore Junior</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Cordeiro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Dioguardi GS, Pimenta J, Knoplich J, Ghorayeb N, Ramos LR, Giannini SD. Fatores de risco para doen&#231;as cardiovasculares em m&#233;dicos: dados preliminaries do projeto VIDAM da Associa&#231;&#227;o Paulista de Medicina. Arq Bras Cardiol. 1994; 62 (6): 383-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fatores de risco para doen&#231;as cardiovasculares em m&#233;dicos: dados preliminaries do projeto VIDAM da Associa&#231;&#227;o Paulista de Medicina</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>383</fpage>
          <lpage>8</lpage>
          <issue>6</issue>
          <volume>62</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dioguardi</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Pimenta</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Knoplich</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ghorayeb</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Giannini</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Fonseca LR, Silva FT, Natividade JE, Schmidt LO. Estudo da preval&#234;ncia de hipertens&#227;o arterial em acad&#234;micos do departamento de ci&#234;ncias m&#233;dicas da Universidade de Taubat&#233;. Arq Bras Cardiol. 1995; 64 (6): 553-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Estudo da preval&#234;ncia de hipertens&#227;o arterial em acad&#234;micos do departamento de ci&#234;ncias m&#233;dicas da Universidade de Taubat&#233;</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>553</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>64</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fonseca</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Natividade</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>LO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Rabelo LM, Viana RM, Schimith MA, Patin RV, Valverde MA, Denadai RC, et al. Fatores de risco para doen&#231;a ateroscler&#243;tica em estudantes de uma universidade privada em S&#227;o Paulo - Brasil. Arq Bras Cardiol. 1999; 72 (5): 569-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fatores de risco para doen&#231;a ateroscler&#243;tica em estudantes de uma universidade privada em S&#227;o Paulo - Brasil</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>569</fpage>
          <lpage>80</lpage>
          <issue>5</issue>
          <volume>72</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rabelo</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Viana</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Schimith</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Patin</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Valverde</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Denadai</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Health Implications of Obesity. National Institutes of Health Consensus Development Conference Statement, 1985. Ann Intern Med. 1985; 103 (6 Pt 2): 1073-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>National Institutes of Health Consensus Development Conference Statement, 1985</article-title>
          <source>Ann Intern Med</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>1073</fpage>
          <lpage>7</lpage>
          <issue>6 Pt 2</issue>
          <volume>103</volume>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de Endocrinologia e Metabologia. Sociedade Brasileira de Diabetes. I Diretriz brasileira de diagn&#243;stico e tratamento da s&#237;ndrome metab&#243;lica. Arq Bras Cardiol. 2005; 84 (supl 1): 3-28.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Sociedade Brasileira de Endocrinologia e Metabologia: Sociedade Brasileira de Diabetes. I Diretriz brasileira de diagn&#243;stico e tratamento da s&#237;ndrome metab&#243;lica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>3</fpage>
          <lpage>28</lpage>
          <volume>84</volume>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Sociedade Brasileira de Cardiologia. V Diretrizes brasileiras de hipertens&#227;o arterial. Arq Bras Cardiol. 2007; 89 (3): e24-e79.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>V Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>e24</fpage>
          <lpage>e79</lpage>
          <issue>3</issue>
          <volume>89</volume>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Fredricklson DS, Levy RI, Less RS. Fat transport in lipoproteins: an integrated approach to mechanisms and disorders. N Engl J Med. 1967; 276 (5): 273-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fat transport in lipoproteins: an integrated approach to mechanisms and disorders</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1967</year>
          </date>
          <fpage>273</fpage>
          <lpage>81</lpage>
          <issue>5</issue>
          <volume>276</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fredricklson</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Less</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Bowden RG, Kingery PM, Long L. Precision of a dry-chemistry method of lipid screening. Public Health. 2006; 120 (6): 572-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Precision of a dry-chemistry method of lipid screening</article-title>
          <source>Public Health</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>572</fpage>
          <lpage>6</lpage>
          <issue>6</issue>
          <volume>120</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bowden</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Kingery</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Long</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. NCEP III. Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Panel Tretament III). JAMA. 2001; 285 (19): 2486-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Panel Tretament III)</article-title>
          <source>JAMA</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2486</fpage>
          <lpage>97</lpage>
          <issue>19</issue>
          <volume>285</volume>
          <person-group person-group-type="author">
            <name>
              <surname>NCEP</surname>
              <given-names>III</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Chen ET, Nichols JH, Duh SH, Hortin G. Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther. 2003; 5 (5): 749-69.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Performance evaluation of blood glucose monitoring devices</article-title>
          <source>Diabetes Technol Ther</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>749</fpage>
          <lpage>69</lpage>
          <issue>5</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Duh</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Hortin</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Mira GS, Candido LMB, Yake JF. Performance of glucometer used for self-monitoring blood glycaemia in Type 1 diabetic patients. Arq Bras Endocrinol Metab. 2006; 50 (3): 541-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Performance of glucometer used for self-monitoring blood glycaemia in Type 1 diabetic patients</article-title>
          <source>Arq Bras Endocrinol Metab</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>541</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mira</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Candido</surname>
              <given-names>LMB</given-names>
            </name>
            <name>
              <surname>Yake</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Lotufo PA. Increasing obesity in Brazil: predicting a new peak of cardiovascular mortality. S&#227;o Paulo Med J. 2000; 118: 161-2.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Increasing obesity in Brazil: predicting a new peak of cardiovascular mortality</article-title>
          <source>S&#227;o Paulo Med J</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>161</fpage>
          <lpage>2</lpage>
          <volume>118</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lotufo</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Virgin SE, Schimitke JA. Metabolic syndrome. AAOHN J. 2003; 51: 28-37.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Metabolic syndrome</article-title>
          <source>AAOHN J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>28</fpage>
          <lpage>37</lpage>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Virgin</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Schimitke</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Haffner S, Taegtmeyr H. Epidemic obesity and the metabolic syndrome. Circulation. 2003; 108 (13): 1541-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Epidemic obesity and the metabolic syndrome</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1541</fpage>
          <lpage>5</lpage>
          <issue>13</issue>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Haffner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Taegtmeyr</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Minist&#233;rio da Sa&#250;de. Inqu&#233;rito domiciliar sobre o comportamento de risco e morbidade referida de doen&#231;as e agravos n&#227;o-transmiss&#237;veis. Bras&#237;lia; 2004.</mixed-citation>
        <element-citation publication-type="book">
          <source>Inqu&#233;rito domiciliar sobre o comportamento de risco e morbidade referida de doen&#231;as e agravos n&#227;o-transmiss&#237;veis</source>
          <date>
            <year>2004</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Guimar&#227;es AC, Lima M, Mota E. The cholesterol level of a selected level of a selected brazilian salaried population: biological and socioeconomic influences. Cardiovasc Dis Prev. 1998; 1: 306-17.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The cholesterol level of a selected level of a selected brazilian salaried population: biological and socioeconomic influences</article-title>
          <source>Cardiovasc Dis Prev</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>306</fpage>
          <lpage>17</lpage>
          <volume>1</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mota</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Jardim PC, Gondim MR, Monego ET, Moreira HG, Vitorino PV, Souza WK, et al. Hipertens&#227;o arterial e alguns fatores de risco em uma capital brasileira. Arq Bras Cardiol. 2007; 88 (4): 452-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hipertens&#227;o arterial e alguns fatores de risco em uma capital brasileira</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>452</fpage>
          <lpage>7</lpage>
          <issue>4</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jardim</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Gondim</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Vitorino</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>WK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28.	Physicians' Health Study. [Acesso em 2009 ago 11]. Dispon&#237;vel em <ext-link ext-link-type="uri" xlink:href="http://www.phs.bwh.harvard.edu/news.htm">http://www.phs.bwh.harvard.edu/news.htm</ext-link></mixed-citation>
        <element-citation publication-type="webpage">
          <comment>Available at:<ext-link ext-link-type="uri" xlink:href="http://http://www.phs.bwh.harvard.edu/news.htm">link</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Monego ET, Jardim PCBV. Determinantes de risco para doen&#231;as cardiovasculares em escolares. Arq Bras Cardiol. 2006; 87 (1): 37-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Determinantes de risco para doen&#231;as cardiovasculares em escolares</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>37</fpage>
          <lpage>45</lpage>
          <issue>1</issue>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Monego</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Jardim</surname>
              <given-names>PCBV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Factores de riesgo cardiovasculares en cohorte de profesionales del &#225;rea m&#233;dica: 15 a&#241;os de evoluci&#243;n</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: Seg&#250;n la Organizaci&#243;n Mundial de Salud (OMS), las enfermedades cardiovasculares (ECV) son responsables de 16,7 millones de muertes/a&#241;o. Evidencias muestran que las ECV resultan de la interacci&#243;n entre factores de riesgo variados, presentes desde la infancia. OBJETIVO: Verificar, en profesionales del &#225;rea m&#233;dica, la presencia y evoluci&#243;n de algunos factores de riesgo cardiovasculares (FRCV) en un intervalo de 15 a&#241;os. M&#201;TODOS: Analizamos a un grupo de individuos al ingresar en la facultad de medicina y hemos repetido el an&#225;lisis tras 15 a&#241;os, comparando los datos encontrados. Utilizamos cuestionarios sobre FRCV (hipertensi&#243;n arterial sist&#233;mica (HAS), diabetes melito (DM), dislipidemia e historia familiar de ECV precoz, tabaquismo, etilismo y sedentarismo). El colesterol, la glucemia, el PA, el peso, la altura, el &#237;ndice de masa corp&#243;rea (IMC) fueron determinados. RESULTADOS: Comparamos a 100 individuos (siendo el 64% varones con edad promedio de 19,9 a&#241;os), con los 72 (siendo un 62,5% varones, 34,8 a&#241;os) incluidos 15 a&#241;os despu&#233;s. Hubo un aumento en la prevalencia de HAS (6,0% vs 16,7%, p = 0,024), exceso de peso (9,0% vs 26,4%, p = 0,002) y dislipidemia (4,0% vs 19,14%, p = 0,002). Los dem&#225;s FRCV no se modificaron. En el an&#225;lisis de los valores de presi&#243;n arterial sist&#243;lica (PAS), presi&#243;n arterial diast&#243;lica (PAD), colesterol, glucemia e IMC, encontramos elevaci&#243;n en el promedio de todas las variables (p &lt; 0,05). Hubo correlaci&#243;n positiva entre valores de PAS, PAD, IMC y glucemia en el intervalo de tiempo evaluado (p &lt; 0,05). CONCLUSI&#211;N: En profesionales del &#225;rea m&#233;dica, encontramos elevaci&#243;n en la PAS, PAD, glucemia, IMC y colesterol en 15 a&#241;os. En el an&#225;lisis de la prevalencia de FRCV, hubo aumento de hipertensi&#243;n arterial, exceso de peso y dislipidemia.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Factores de riesgo</kwd>
        <kwd>personal de salud</kwd>
        <kwd>estudios transversales</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Factores de riesgo cardiovasculares en cohorte de profesionales del &#225;rea m&#233;dica - 15 a&#241;os de evoluci&#243;n</bold>
          </label>
          <p>
            <bold>Thiago de Souza Veiga Jardim; Paulo C&#233;sar Brand&#227;o Veiga Jardim; Wattusy Estefane Cunha de Ara&#250;jo; Luciana Muniz Sanches Siqueira Veiga Jardim; Claudia Maria Salgado</bold>
          </p>
        </fn>
      </p>
      <p>Universidade Federal de Goi&#225;s, Goi&#226;nia, GO - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> Seg&#250;n la Organizaci&#243;n Mundial de Salud (OMS), las enfermedades cardiovasculares (ECV) son responsables de 16,7 millones de muertes/a&#241;o. Evidencias muestran que las ECV resultan de la interacci&#243;n entre factores de riesgo variados, presentes desde la infancia.</p>
      <p><bold>OBJETIVO:</bold> Verificar, en profesionales del &#225;rea m&#233;dica, la presencia y evoluci&#243;n de algunos factores de riesgo cardiovasculares (FRCV) en un intervalo de 15 a&#241;os.</p>
      <p><bold>M&#201;TODOS:</bold> Analizamos a un grupo de individuos al ingresar en la facultad de medicina y hemos repetido el an&#225;lisis tras 15 a&#241;os, comparando los datos encontrados. Utilizamos cuestionarios sobre FRCV (hipertensi&#243;n arterial sist&#233;mica (HAS), diabetes melito (DM), dislipidemia e historia familiar de ECV precoz, tabaquismo, etilismo y sedentarismo). El colesterol, la glucemia, el PA, el peso, la altura, el &#237;ndice de masa corp&#243;rea (IMC) fueron determinados.</p>
      <p><bold>RESULTADOS:</bold> Comparamos a 100 individuos (siendo el 64% varones con edad promedio de 19,9 a&#241;os), con los 72 (siendo un 62,5% varones, 34,8 a&#241;os) incluidos 15 a&#241;os despu&#233;s. Hubo un aumento en la prevalencia de HAS (6,0% <italic>vs</italic> 16,7%, p = 0,024), exceso de peso (9,0% <italic>vs</italic> 26,4%, p = 0,002) y dislipidemia (4,0% <italic>vs</italic> 19,14%, p = 0,002). Los dem&#225;s FRCV no se modificaron. En el an&#225;lisis de los valores de presi&#243;n arterial sist&#243;lica (PAS), presi&#243;n arterial diast&#243;lica (PAD), colesterol, glucemia e IMC, encontramos elevaci&#243;n en el promedio de todas las variables (p &lt; 0,05). Hubo correlaci&#243;n positiva entre valores de PAS, PAD, IMC y glucemia en el intervalo de tiempo evaluado (p &lt; 0,05).</p>
      <p><bold>CONCLUSI&#211;N: </bold> En profesionales del &#225;rea m&#233;dica, encontramos elevaci&#243;n en la PAS, PAD, glucemia, IMC y colesterol en 15 a&#241;os. En el an&#225;lisis de la prevalencia de FRCV, hubo aumento de hipertensi&#243;n arterial, exceso de peso y dislipidemia.</p>
      <p><bold>Palabras clave: </bold> Factores de riesgo, personal de salud/tendencias, estudios transversales.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Seg&#250;n la Organizaci&#243;n Mundial de Salud (OMS), las enfermedades cardiovasculares (ECV) son responsables de 16,7 millones de muertes por a&#241;o. Las proyecciones para 2020 mantienen estos da&#241;os como la principal causa de muerte e incapacitaci&#243;n y, actualmente, las regiones en desarrollo contribuyen m&#225;s marcadamente para el gravamen de estas enfermedades que las regiones desarrolladas<sup>1</sup>. En Brasil, se estima que las ECV respondan por m&#225;s del 30% de las defunciones en personas a partir de los 20 a&#241;os de edad<sup>2</sup>.</p>
      <p>La literatura presenta claras evidencias de que las ECV manifiestas en la edad adulta resultan de una compleja interacci&#243;n entre factores de riesgo variados presentes desde la ni&#241;ez y adolescencia<sup>3</sup>.</p>
      <p>Gran parte de estos conocimientos acerca de los factores de riesgo cardiovasculares (FRCV) advienen del consagrado estudio de Framingham<sup>4</sup>. Se trata de una de las primeras cohortes donde se demostr&#243; la importancia de algunos factores de riesgo para el desarrollo de enfermedades card&#237;acas y cerebrovasculares. En 2004, Yusuf et al publicaron el estudio INTERHEART<sup>5</sup>, que fue una investigaci&#243;n de caso-control internacional, delineada para evaluar de forma sistematizada la importancia de factores de riesgo para enfermedad arterial coronaria alrededor del mundo. En esta evaluaci&#243;n, 9 factores de riesgo explicaron m&#225;s del 90% del riesgo atribuible para IAM. Aunque con algunas diferencias regionales, estos datos contempor&#225;neos confirmaron los factores de riesgo tradicionales, previamente establecidos<sup>5</sup>.</p>
      <p>Los datos referentes a los FRCV son raros en Am&#233;rica Latina<sup>6</sup>. En Brasil, la situaci&#243;n no es diferente. Esto ocurre tanto en el que se refiere a la incidencia y en cuanto a la prevalencia, sin embargo especialmente con relaci&#243;n a la evaluaci&#243;n evolutiva de estos FRCV en la poblaci&#243;n<sup>7-12</sup>.</p>
      <p>El conocimiento sobre los FRCV, la presencia de estos factores en poblaciones de baja edad, su evoluci&#243;n a lo largo del tiempo, as&#237; como la evaluaci&#243;n de comportamientos de riesgo, pueden contribuir de manera significativa para las acciones que modifiquen la historia natural de estos riesgos, permitiendo la prevenci&#243;n de la aparici&#243;n de las enfermedades cardiovasculares<sup>11-13</sup>.</p>
      <p>Con este objetivo, estudiamos en una poblaci&#243;n, que inicialmente era de estudiantes de medicina, y en el momento siguiente, estaba constituida por profesionales por del &#225;rea m&#233;dica, la presencia y la evoluci&#243;n de los factores de riesgo cardiovasculares en un intervalo de 15 a&#241;os.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>El proyecto de investigaci&#243;n se evalu&#243; y aprob&#243; por el Comit&#233; de &#201;tica en Investigaci&#243;n M&#233;dica Humana y Animal del Hospital de Cl&#237;nicas de la Facultad de Medicina de la Universidad Federal de Goi&#225;s.</p>
      <p>Se trata de un estudio de cohorte hist&#243;rica, en el que la poblaci&#243;n estudiada estaba conformada por acad&#233;micos de la Facultad de Medicina de la Universidad Federal de Goi&#225;s que iniciaron el curso en el a&#241;o de 1993. Los mismos individuos han sido reevaluados tras 15 a&#241;os, ya como profesionales dentro de las diversas especialidades m&#233;dicas. As&#237; siendo, el estudio se desarroll&#243; en dos etapas.</p>
      <p>Se excluyeron aquellos que no concordaron en participar en cualquier etapa del estudio, los portadores de cardiopat&#237;a cong&#233;nita, de diabetes melito tipo 1, y aquellos que no estaban inscriptos en el Consejo Regional de Medicina, a la &#233;poca de la segunda etapa del estudio.</p>
      <p>En la primera fase, los sujetos de la investigaci&#243;n se seleccionaron en fechas predeterminadas agendadas con la direcci&#243;n de la facultad, y en la segunda fase, se localizaron a trav&#233;s del Consejo Regional de Medicina de Goi&#225;s, por llamada telef&#243;nica y posterior agendamiento de entrevista para recolecci&#243;n de datos. Para individuos que no resid&#237;an en la Grande Goi&#226;nia, esta recolecci&#243;n se llev&#243; a cabo por tel&#233;fono. Los datos referidos, en estos casos espec&#237;ficos, se consideraron para el an&#225;lisis final. Todos los participantes fueron informados sobre los procedimientos del estudio en 1993 y firmaron un formulario de consentimiento informado, con el mismo procedimiento repetido en la etapa posterior.</p>
      <p>El cuestionario utilizado en 1993 se aplic&#243; nuevamente tras 15 a&#241;os, siendo las mismas variables interrogadas. Fueron ellas: edad, sexo, diagn&#243;stico y tratamiento previo de hipertensi&#243;n arterial sist&#233;mica, dislipidemia o diabetes. Los individuos fueron cuestionados todav&#237;a sobre la ocurrencia de evento cardiovascular mayor (infarto agudo de miocardio - IAM, accidente cerebrovascular - ACV, o necesidad de revascularizaci&#243;n del miocardio - RVM).</p>
      <p>En cuanto a los h&#225;bitos de vida, se analiz&#243; el hist&#243;rico de tabaquismo (fumador o no fumador), etilismo (ingesta de bebida alcoh&#243;lica o no) y pr&#225;ctica de actividad f&#237;sica (sedentario - sin cualquier actividad f&#237;sica, actividad f&#237;sica irregular - cuando menos de 30 minutos por tres veces/semana y regular - cuando mayor o igual a 30 minutos tres veces/semana). La presencia de enfermedad cardiovascular precoz en familiar de primer grado (&lt; 65 a&#241;os para mujeres y &lt; 55 a&#241;os para varones) tambi&#233;n se consider&#243;.</p>
      <p>
        <bold>Mediciones objetivas</bold>
      </p>
      <p>En la primera y segunda etapas, las siguientes variables fueron evaluadas con las mismas metodolog&#237;as del estudio:</p>
      <p><italic>Peso -</italic> individuos vestidos con ropas ligereas y sin calzados, con la utilizaci&#243;n de balanza electr&#243;nica de la marca Plenna Lithium, con capacidad m&#225;xima de 150 kg y precisi&#243;n de 100 g.</p>
      <p><italic>Altura -</italic> individuos descalzos, utilizando estadi&#243;metro SECCA a laser, modelo 206, con precisi&#243;n de 0,1 cm.</p>
      <p><italic>&#205;ndice de masa corp&#243;rea (IMC)</italic> - a trav&#233;s de la f&#243;rmula establecida por Quetelet (IMC = peso en kg/altura<sup>2</sup> en metro)<sup>14</sup>. Valores de IMC <underline>&gt;</underline>25 kg/m<sup>2</sup> fueron considerados como exceso de peso<sup>15</sup>.</p>
      <p><italic>Presi&#243;n arterial (PA)</italic> - aparatos semiautom&#225;ticos de la marca OMRON HEM705 CP calculados se utilizaron. Las mediciones se realizaron tras 5 minutos de reposo, en el miembro superior derecho, con el individuo en la posici&#243;n sentada y con el brazo apoyado. Se realizaron so mediciones, con intervalo de dos minutos. Para fines de an&#225;lisis de los datos, se consider&#243; la segunda medici&#243;n de la presi&#243;n arterial, teniendo la hipertensi&#243;n arterial definida por valores mayores o iguales a 140/90 mmHg<sup>16</sup>.</p>
      <p><italic>Circunferencia de la cintura (CC)</italic> - calculada solamente en la segunda etapa del estudio (en el punto medio entre la &#250;ltima costilla y la cresta il&#237;aca al final de la espiraci&#243;n), con cinta m&#233;trica graduada en cent&#237;metros. Considerada aumentada si mayor de 88 cm para mujeres y mayor de 102 cm para varones<sup>15</sup>.</p>
      <p>
        <bold>Datos recolectados por tel&#233;fono</bold>
      </p>
      <p>La recolecci&#243;n de datos por tel&#233;fono se llev&#243; a cabo con 11 individuos. En estos casos, se utilizaron el peso y la altura referidos. A los mismos, se solicitaron la toma de la presi&#243;n arterial con aparato calibrado utilizado en la pr&#225;ctica diaria del m&#233;dico y la medici&#243;n de la circunferencia de la cintura, siguiendo las recomendaciones previstas en el estudio. Por tratarse de profesionales de la salud, no hubo dificultades para la ejecuci&#243;n de tales procedimientos y los datos se consideraron como confiables.</p>
      <p>
        <bold>Datos laboratoriales</bold>
      </p>
      <p>En la primera etapa, tras 12 horas de ayuno, la dosificaci&#243;n de la glucemia y colesterol se realizaba en muestra de sangre extra&#237;da a trav&#233;s de punci&#243;n digital con lanceta, y la lectura realizada a trav&#233;s de m&#233;todo de cinta utilizando los aparatos de HEMOGLUCOTEST y el REFLOTRON, respectivamente.</p>
      <p>Para la segunda etapa, se utilizaron los ex&#225;menes de glucemia de ayuno y perfil lip&#237;dico, llevados a cabo hasta 6 meses antes de la realizaci&#243;n del cuestionario, desde que recolectados tras 12 horas de ayuno y siguiendo la recomendaci&#243;n de la no ingesta de bebida alcoh&#243;lica por 48 h, antecediendo la recolecci&#243;n. Solamente 5 individuos no tienen los resultados de los ex&#225;menes necesarios que se enmarcaran en estos requisitos, siendo que en estos se llev&#243; a cabo una nueva recolecci&#243;n. El m&#233;todo utilizado para la dosificaci&#243;n del colesterol total (CT), HDL colesterol (HDL), triglic&#233;ridos s&#233;ricos (TG) y de la glucemia plasm&#225;tica fue el colorim&#233;trico-enzim&#225;tico para todos las personas incluidas en el an&#225;lisis, aun que la recolecci&#243;n no haya sido realizada en el mismo laboratorio. El valor del LDL colesterol se estim&#243; por la f&#243;rmula de Friedewald, donde LDL = CT - (HDL+ TG/5)<sup>17</sup>.</p>
      <p>Se registraron como dislipid&#233;micos a aquellos que ten&#237;an valores de colesterol total iguales o superiores a 200 mg/dl. Se opt&#243; por no utilizar las fracciones del colesterol y el triglic&#233;ridos en esta evaluaci&#243;n, ya que estos datos no exist&#237;an en el an&#225;lisis inicial de la muestra, imposibilitando as&#237; la comparaci&#243;n.</p>
      <p>Pese a que la metodolog&#237;a empleada para la dosificaci&#243;n de colesterol y la glucemia no sea la misma en las dos etapas del estudio, la literatura ya presenta una amplia documentaci&#243;n en relaci&#243;n con la correlaci&#243;n entre los valores obtenidos por estos m&#233;todos, sin haber con ello un perjuicio en el an&#225;lisis de los datos<sup>18-21</sup>.</p>
      <p>
        <bold>Banco de datos y an&#225;lisis de estad&#237;stica</bold>
      </p>
      <p>Los datos se almacenaron en banco de datos propio, estructurado en el programa Excel (Microsoft) y analizados comparativamente. El an&#225;lisis estad&#237;stica se llev&#243; a cabo a trav&#233;s del Software <italic>SPSS</italic> (<italic>Statistical Package of Social Science</italic>, versi&#243;n 15.0, Chicago, IL, USA). La prueba de Kolmogorov-Smirnov se utiliz&#243; para analizar si las variables continuas presentaban distribuci&#243;n normal. La prueba t de <italic>Student</italic> para muestras pareadas se utiliz&#243; para comparar las variables num&#233;ricas del estudio, expresas en promedio y desviaci&#243;n est&#225;ndar. El an&#225;lisis comparativo de los FRCV entre 1993-2008 se llev&#243; a cabo utilizando la prueba del chi-cuadrado y la prueba de Fisher. El an&#225;lisis de correlaci&#243;n de las variables num&#233;ricas entre las dos etapas del estudio se llev&#243; a cabo por la prueba de correlaci&#243;n de Pearson. Se consideraron como significantes los valores de p&lt;0,05.</p>
      <p>
        <bold>Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue parcialmente financiado con recursos de la Beca de auxilio a la Investigaci&#243;n de la Sociedad Brasile&#241;a de Cardiolog&#237;a (SBC).</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>El banco de datos de la primera etapa del estudio fue compuesto por 100 individuos, de los cuales, tras 15 a&#241;os, 74 (74,0%) fueron localizados para la segunda fase del an&#225;lisis. Se excluyeron a dos individuos, uno por no concordar con participar y otro por haber sido diagnosticado, en este lapso, como diab&#233;tico tipo 1, siendo los datos de 72 m&#233;dicos utilizados para el an&#225;lisis de los datos.</p>
      <p>De los 100 individuos estudiados en 1993, el 39% era del sexo femenino, con edad promedio de 19,9 a&#241;os (m&#237;nimo de 18 y m&#225;ximo de 22 a&#241;os). En el grupo estudiado en 2008, la edad promedio fue de 34,8 a&#241;os (m&#237;nimo 33 y m&#225;ximo 37), con un 37,5% de estos siendo del sexo femenino.</p>
      <p>En la primera etapa del trabajo, ninguno de los acad&#233;micos de medicina afirm&#243; ser portador de hipertensi&#243;n arterial, dislipidemia o diabetes. Ya en el segundo an&#225;lisis, con relaci&#243;n al conocimiento sobre hipertensi&#243;n arterial, un individuo afirm&#243; ser hipertenso y estar bajo tratamiento. Para dislipidemia, este n&#250;mero fue mayor, con 6 personas afirmando ser portadores de desviaci&#243;n del perfil lip&#237;dico, y que solamente tres (50%) estaban bajo tratamiento (farmacol&#243;gico o no). No hubo referencia al conocimiento sobre diabetes tipo 2.</p>
      <p>No se describieron eventos cardiovasculares precoces en familiares de primer grado en 1993, y en 2008 fueron referidos eventos por 15 individuos.</p>
      <p>Ning&#250;n evento cardiovascular se produjo en el grupo evaluado tras 15 a&#241;os de evoluci&#243;n.</p>
      <p>En el an&#225;lisis de las prevalencias de los factores de riesgo cardiovasculares en la poblaci&#243;n estudiada entre 1993-2008, hubo un aumento significativo de hipertensi&#243;n arterial sist&#233;mica, exceso de peso y dislipidemia. Para los dem&#225;s FRCV (sedentarismo, tabaquismo y etilismo), las alteraciones no fueron significativas (<xref ref-type="table" rid="t1-body2">Tabla 1</xref>).</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt01-es.jpg"/></table-wrap>
      <p>La comparaci&#243;n de los valores de presi&#243;n arterial sist&#243;lica (PAS), presi&#243;n arterial diast&#243;lica (PAD), IMC, glucemia y colesterol en los dos momentos mostr&#243; elevaci&#243;n de los valores promedios con diferencia significativa en todas las variables (<xref ref-type="table" rid="t2-body2">Tabla 2</xref>).</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt02-es.jpg"/></table-wrap>
      <p>Al evaluar las mismas variables por sexo, verificamos que en el sexo masculino hay elevaci&#243;n significativa en todas las variables (presi&#243;n sist&#243;lica y diast&#243;lica, IMC, glucemia y colesterol), mientras que en el sexo femenino hay elevaci&#243;n significativa solamente en el IMC, glucemia y colesterol (<xref ref-type="table" rid="t3-body2">Tablas 3</xref> y <xref ref-type="table" rid="t4-body2">4</xref>).</p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt03-es.jpg"/></table-wrap>
      <table-wrap id="t4-body2">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt04-es.jpg"/></table-wrap>
      <p>No hubo diferencia entre la prevalencia de los FRCV, al evaluar cada uno de los sexos separadamente, a excepci&#243;n realizada al exceso de peso. En esta variable, entre los varones, encontramos 6 (13,33%) individuos con IMC <underline>&gt;</underline>25 kg/m&#178; en 1993, mientras que, en 2008, ya eran 14 (31,1%) j&#243;venes con esta clasificaci&#243;n de IMC (p &lt; 0,001).</p>
      <p>En el an&#225;lisis de correlaci&#243;n entre los valores obtenidos en 1993 y 2008, verificamos correlaci&#243;n positiva entre valores de presi&#243;n arterial sist&#243;lica, diast&#243;lica, IMC y glucemia (p &lt; 0,001). Para el colesterol, tal correlaci&#243;n no se demostr&#243; (r = 0,186, p = 0,117;) (<xref ref-type="fig" rid="es_09f01-body2">Figura 1</xref>).</p>
      <p content-type="asset">
        <fig id="es_09f01-body2">
          <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gf01-es.jpg"/></fig>
      </p>
      <p>La circunferencia de la cintura se evalu&#243; solamente en la segunda etapa del trabajo, imposibilitando la comparaci&#243;n. Se encontraron 9 (12,5%) individuos con aumento de la CC, siendo tres mujeres y 6 varones.</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>Este estudio detect&#243; un aumento significativo en la prevalencia de algunos factores de riesgo cardiovasculares (exceso de peso, dislipidemia y hipertensi&#243;n arterial sist&#233;mica) en la poblaci&#243;n estudiada. Estos hallazgos no se repitieron en los otros factores de riesgo cardiovasculares analizados. Tabaquismo, sedentarismo y etilismo fueron aspectos comportamentales que no se alteraron de forma significativa a lo largo del per&#237;odo evaluado.</p>
      <p>El aumento de la prevalencia y del exceso de peso a lo largo del tiempo ya se detect&#243; por algunos estudios brasile&#241;os, entre ellos los estudios de Ciorlia y Lotufo, con an&#225;lisis de evoluci&#243;n del IMC en poblaciones espec&#237;ficas<sup>9,22</sup>. Adem&#225;s de ello, la epidemia de obesidad ya es una realidad en pa&#237;ses desarrollados, y tambi&#233;n se viene observando en los pa&#237;ses en desarrollo<sup>23,24</sup>. Nuestro grupo de estudio, aun siendo diferenciado por su educaci&#243;n formal en el &#225;rea de salud, no present&#243; evoluci&#243;n diferente. Todav&#237;a as&#237;, las prevalencias de exceso de peso fueron menores en los dos momentos del an&#225;lisis, cuando comparadas con las de la poblaci&#243;n de capitales brasile&#241;as en los mismos grupos de edad<sup>25</sup>.</p>
      <p>La prevalencia de la dislipidemia, aun teniendo se elevado de forma significativa a lo largo del estudio, fue muy inferior a los datos de la literatura producida en Brasil, en los dos momentos de la evaluaci&#243;n. Levantamientos de individuos, de 9 capitales, con edad promedio de 35,4 a&#241;os, en este aspecto bastante semejante a la poblaci&#243;n de la segunda etapa de nuestro an&#225;lisis, indican prevalencia de colesterol total <underline>&gt;</underline>200 mg/dl del 38% para el sexo masculino y el 42% para el femenino<sup>26</sup>. Nuestros datos mostraron solamente un 19,4% para ambos sexos.</p>
      <p>Al comparar el n&#250;mero de individuos hipertensos, en el grupo por nosotros estudiado en los dos momentos, con la poblaci&#243;n de Goi&#226;nia<sup>27</sup> dividida por grupo de edad, encontramos menores &#237;ndices de HAS en nuestro grupo en los dos per&#237;odos, a pesar da detecci&#243;n del aumento de la prevalencia de HAS, a lo largo de los 15 a&#241;os. Estas informaciones corroboran la relaci&#243;n entre la hipertensi&#243;n arterial y de bajos niveles de escolaridad, una vez que la poblaci&#243;n de nuestro estudio es conformada, en un primer momento, por universitarios, y, en un segundo momento, por profesionales con curso superior completo, por tanto, con mayor grado de instrucci&#243;n cuando comparada a la poblaci&#243;n general de Goi&#226;nia.</p>
      <p>Nuestro estudio demostr&#243; que aun entre los factores de riesgo cardiovasculares que aumentaron su prevalencia de forma significativa con el paso de los 15 a&#241;os de seguimiento, estas prevalencias fueron menores que en la poblaci&#243;n general. Estos datos son superponibles a los encontrados en el <italic>Physicians Health Study</italic><sup>28</sup>, donde se demostr&#243; una prevalencia de factores de riesgo cardiovasculares substancialmente menor entre los m&#233;dicos americanos cuando comparados a la poblaci&#243;n general.</p>
      <p>Datos de una encuesta domiciliaria del Ministerio de la Salud revelaron prevalencia de tabaquismo variando de 12,9-25,2%, dependiendo de la ciudad analizada, con aumento de esta prevalencia en individuos con menor grado de escolaridad y de mayores grupos de edad<sup>25</sup>. Teniendo en cuenta las prevalencias del 1% y un 5,6% en los dos momentos de nuestra investigaci&#243;n, concluimos que los profesionales de salud analizados en este estudio fuman menos que la poblaci&#243;n general, obedeciendo al mismo est&#225;ndar de distribuci&#243;n por edad de la poblaci&#243;n de las capitales brasile&#241;as.</p>
      <p>En el grupo que investigamos, el sedentarismo se identific&#243; en el 35% en la primera fase y un 27,8% en la segunda, pero esta reducci&#243;n no tuvo significancia estad&#237;stica. En la poblaci&#243;n de 9 capitales brasile&#241;as, este factor de riesgo para enfermedades cardiovasculares vari&#243; de un 28,2% a un 54,5%, sin embargo, diferentemente de lo que encontramos, la poblaci&#243;n tendi&#243; a ser m&#225;s activa entre los 15 a 24 a&#241;os. Otro dato interesante es la ausencia de la influencia del grado de escolaridad sobre la prevalencia de sedentarismo<sup>25</sup>, datos que confirman nuestros hallazgos.</p>
      <p>El consumo de alcohol no present&#243; variaci&#243;n significativa, con prevalencias en los dos momentos estudiados semejantes a las de la poblaci&#243;n de capitales brasile&#241;as. Debemos destacar que no encontramos en nuestro estudio la tendencia al aumento del consumo de bebidas alcoh&#243;licas con el aumento de la edad y del grado de escolaridad<sup>25</sup>.</p>
      <p>Separando la evoluci&#243;n de las prevalencias de los factores de riesgo por sexo, entre los dos momentos, encontramos diferencia solamente en el exceso de peso, siendo mayor en el sexo masculino. Todos los dem&#225;s FRCV, cuando analizados por sexo, no se cambiaron a lo largo de los a&#241;os. Tal hecho sugiere que, en este grupo de individuos, la evoluci&#243;n de estas prevalencias se produce de forma homog&#233;nea entre los dos sexos, a excepci&#243;n del exceso de peso. Sin embargo, la muestra no fue grande el suficiente para demostrar con seguridad diferencias en la evoluci&#243;n entre los sexos.</p>
      <p>En el an&#225;lisis num&#233;rico de los niveles de presi&#243;n, valores de colesterol, glucemia e IMC, se evidenci&#243; la elevaci&#243;n significativa en todas estas variables con el paso de los 15 a&#241;os, tal vez por el propio envejecimiento de la poblaci&#243;n estudiada. Observando estas mismas variables por sexo. Detectamos aumento significativo de IMC, glucemia y colesterol en ambos sexos, mientras que para la presi&#243;n arterial (sist&#243;lica y diast&#243;lica) el aumento s&#243;lo fue significativo para el sexo masculino.</p>
      <p>En el estudio de la correlaci&#243;n entre los valores obtenidos en 1993 con los de 2008, encontramos una n&#237;tida correlaci&#243;n positiva entre PAD, PAS, glucemia e IMC, es decir, los mismos individuos que presentaban niveles m&#225;s altos en 1993, los presentaron en 2008. Ya los valores de colesterol no se correlacionaron entre los dos momentos del estudio. En un an&#225;lisis m&#225;s detallado de estos datos, se observ&#243; mayor correlaci&#243;n (valores de r mayores) para la presi&#243;n arterial sist&#243;lica e &#237;ndice de masa corp&#243;rea, sugiriendo que el monitoreo y el abordaje m&#225;s agresivo sobre el control de estas variables podr&#237;an tener mayor impacto como mediciones de promoci&#243;n de salud, a pesar de los valores de <italic>p</italic> haber mostrado resultados significativos con relaci&#243;n a la comparaci&#243;n de todas las variables consideradas anteriormente.</p>
      <p>As&#237; como ya sugirieron Monego y Jardim, al estudiar los determinantes de riesgo para enfermedades cardiovasculares en escolares<sup>29</sup>, estos datos pueden utilizarse en estrategias de intervenci&#243;n precoz sobre factores de riesgo cambiables.</p>
      <p>Algunas limitaciones de nuestro trabajo se deben mencionar. Una de ellas est&#225; en el hecho de la no localizaci&#243;n, en 2008, de todos los individuos evaluados en 1993. Esto se justifica por el largo intervalo de tiempo entre las dos recolecciones de datos, siendo que en este per&#237;odo no se mantuvo ning&#250;n contacto con estos sujetos de l investigaci&#243;n. A pesar de esto, la reevaluaci&#243;n de m&#225;s del 70% de los individuos del grupo inicial vuelve la muestra representativa y permite las conclusiones presentadas.</p>
      <p>Las muestras de glucemia y perfil lip&#237;dico en la segunda evaluaci&#243;n tambi&#233;n merecen menci&#243;n. Estas muestras se obtuvieron en laboratorios diferentes y, en una parte de estos m&#233;dicos (11 individuos, un 15,27% de la muestra estudiada en la segunda evaluaci&#243;n), los resultados fueron obtenidos por llamada telef&#243;nica. Un dato a destacar es que la metodolog&#237;a empleada en el an&#225;lisis de la variables bioqu&#237;micas fue la misma (colorim&#233;trico-enzim&#225;tico), independiente de la variaci&#243;n del laboratorio o de la recolecci&#243;n haber sido realizada por llamada telef&#243;nica. Se resalta a&#250;n la calidad de las informaciones recolectadas por llamada telef&#243;nica, ya que se trataban de profesionales m&#233;dicos.</p>
      <p>Otra limitaci&#243;n a observar fue la utilizaci&#243;n, en las dos etapas de la investigaci&#243;n, de metodolog&#237;as diferentes para an&#225;lisis del colesterol y glucemia. A pesar de la metodolog&#237;a empleada no haber sido la misma, ya existe en la literatura una amplia documentaci&#243;n que confirma la correlaci&#243;n entre los valores obtenidos por tales m&#233;todos, sin haber con ello perjuicio en el an&#225;lisis de los datos<sup>18-21</sup>. Adem&#225;s de ello, el an&#225;lisis del perfil lip&#237;dico y de la glucemia s&#233;rica ampl&#237;a las posibilidades de abordajes futuras de esta poblaci&#243;n en lo que toca a estos factores, que son importantes determinantes de riesgo cardiovascular.</p>
      <p>
        <bold>Conclusiones</bold>
      </p>
      <p>En una corte de profesionales del &#225;rea m&#233;dica, encontramos elevaci&#243;n en la PAS, PAD, glucemia, IMC y colesterol en 15 a&#241;os de evoluci&#243;n. En el an&#225;lisis de la prevalencia de factores de riesgo cardiovascular, se observ&#243; un aumento de la prevalencia de hipertensi&#243;n arterial sist&#233;mica, exceso de peso y dislipidemia.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue parcialmente financiado con recursos de la Beca de auxilio a la Investigaci&#243;n de la Sociedad Brasile&#241;a de Cardiolog&#237;a.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de disertaci&#243;n de Maestr&#237;a de Thiago de Souza Veiga Jardim por la Universidad Federal de Goi&#225;s.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Cardiovascular risk factors in a cohort of healthcare professionals: 15 years of evolution</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: According to the World Health Organization (WHO), cardiovascular diseases (CVD) account for 16.7 million deaths per year. Evidence shows that CVD result from the interaction of multiple risk factors that are present from childhood. OBJECTIVE: To evaluate the presence and evolution of several cardiovascular risk factors (CVRF) among medical professionals, in a period of 15 years. METHODS: We analyzed a group of individuals when they entered medical school, and repeated the analysis after 15 years, comparing the data found. We used CVRF questionnaires (systemic arterial hypertension (SAH); diabetes mellitus (DM); dyslipidemia and family history of premature CVD; smoking habit; alcoholism; and sedentary lifestyle). Cholesterol, blood glucose, BP, weight, height, body mass index (BMI) values were determined. RESULTS: We compared 100 subjects (64.0% men with a mean age of 19.9 years) with a total of 72 subjects (62.5% men, 34.8 years) that were included in the study 15 years later. There was an increase in the prevalence of hypertension (6.0% vs 16.7%, p = 0.024), overweight (9.0% vs 26.4%, p = 0.002), and dyslipidemia (4.0% vs 19.14%, p = 0.002). The other CVRF remained unchanged. Analyzing the values of systolic blood pressure (SBP); diastolic blood pressure (DBP); cholesterol; glucose; and BMI, we found an increase in the mean values of all variables (p &lt; 0.05). We observed a positive correlation between the values of SBP, DBP, BMI, and blood glucose measured in the time interval (p &lt; 0.05). CONCLUSION: Among medical professionals, there was an elevation in SBP, DBP, glucose, BMI, and cholesterol values in 15 years. In the CVRF prevalence analysis, we found an increase in the prevalence of hypertension, overweight, and dyslipidemia.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Risk factors</kwd>
        <kwd>health personnel</kwd>
        <kwd>cross-sectional studies</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLES</bold>
      </p>
      <p>
        <fn id="enda-body3">
          <label>
            <bold>Cardiovascular risk factors in a cohort of healthcare professionals - 15 years of evolution</bold>
          </label>
          <p>
            <bold>Thiago de Souza Veiga Jardim; Paulo C&#233;sar Brand&#227;o Veiga Jardim; Wattusy Estefane Cunha de Ara&#250;jo; Luciana Muniz Sanches Siqueira Veiga Jardim; Claudia Maria Salgado</bold>
          </p>
        </fn>
      </p>
      <p>Universidade Federal de Goi&#225;s, Goi&#226;nia, GO - Brasil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> According to the World Health Organization (WHO), cardiovascular diseases (CVD) account for 16.7 million deaths per year. Evidence shows that CVD result from the interaction of multiple risk factors that are present from childhood.</p>
      <p><bold>OBJECTIVE:</bold> To evaluate the presence and evolution of several cardiovascular risk factors (CVRF) among medical professionals, in a period of 15 years.</p>
      <p><bold>METHODS:</bold> We analyzed a group of individuals when they entered medical school, and repeated the analysis after 15 years, comparing the data found. We used CVRF questionnaires (systemic arterial hypertension (SAH); diabetes mellitus (DM); dyslipidemia and family history of premature CVD; smoking habit; alcoholism; and sedentary lifestyle). Cholesterol, blood glucose, BP, weight, height, body mass index (BMI) values were determined.</p>
      <p><bold>RESULTS:</bold> We compared 100 subjects (64.0% men with a mean age of 19.9 years) with a total of 72 subjects (62.5% men, 34.8 years) that were included in the study 15 years later. There was an increase in the prevalence of hypertension (6.0% <italic>vs</italic> 16.7%, p = 0.024), overweight (9.0% <italic>vs</italic> 26.4%, p = 0.002), and dyslipidemia (4.0% <italic>vs</italic> 19.14%, p = 0.002). The other CVRF remained unchanged. Analyzing the values of systolic blood pressure (SBP); diastolic blood pressure (DBP); cholesterol; glucose; and BMI, we found an increase in the mean values of all variables (p &lt; 0.05). We observed a positive correlation between the values of SBP, DBP, BMI, and blood glucose measured in the time interval (p &lt; 0.05).</p>
      <p><bold>CONCLUSION:</bold> Among medical professionals, there was an elevation in SBP, DBP, glucose, BMI, and cholesterol values in 15 years. In the CVRF prevalence analysis, we found an increase in the prevalence of hypertension, overweight, and dyslipidemia.</p>
      <p><bold>Key words:</bold> Risk factors; health personnel/trends; cross-sectional studies.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>According to the World Health Organization (WHO), cardiovascular diseases (CVD) account for 16.7 million deaths per year. The projection of the prevalence of CVD for 2020 estimates them as the main cause of death and disability. Currently, developing regions contribute more to the burden of these diseases than developed regions<sup>1</sup>. In Brazil, it is estimated that CVD account for over 30.0% of deaths among adults 20 years of age or older<sup>2</sup>. </p>
      <p>The literature provides clear evidence that CVD manifestations in adulthood result from a complex interaction of multiple risk factors that are present from childhood and adolescence<sup>3</sup>. </p>
      <p>Much of this knowledge about cardiovascular risk factors (CRF) results from the Framingham study<sup>4</sup>. This was one of the first cohorts in which the importance of some risk factors for developing heart disease and stroke were demonstrated. In 2004, Yusuf et al published the INTERHEART study<sup>5</sup>, which was an international case-control investigation, outlined to systematically assess the importance of risk factors for coronary artery disease around the world. In this evaluation, nine risk factors accounted for more than 90.0% of the attributable risk for AMI. Albeit some regional differences, these contemporary data confirmed the traditional risk factors that had been previously established.<sup>5</sup></p>
      <p>Data regarding CVRF are scarce in Latin America<sup>6</sup>. In Brazil, the situation is not different. This occurs both with regard to the incidence and the prevalence, but especially in relation to an evolution analysis of these CVRF in the population<sup>7-12</sup>. </p>
      <p>Knowledge about the CVRF, the presence of these factors among children and youth population, and their evolution over time, as well as an assessment of risk behaviors, may contribute significantly to actions that could change the natural history of these risks, enabling the prevention of the onset of cardiovascular diseases<sup>11-13</sup>. </p>
      <p>With this objective in mind, we studied the presence and the evolution of cardiovascular risk factors in a population, which initially was composed of medical students, and in a later instance included medical professionals, in a period of 15 years. </p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The research project was evaluated and approved by the Ethics Commission in Human and Animal Medical Research of the Hospital of the School of Medicine of the Federal University of Goias.</p>
      <p>This was a historical cohort study conducted in a population composed of students of the School of Medicine of the Federal University of Goi&#225;s who started the course in 1993. The same subjects were reassessed after 15 years, now as professionals in various medical specialties. Therefore, the study was conducted in two stages. </p>
      <p>We excluded those who did not agree to participate in any of the stages of the study, patients with congenital heart disease, patients with type 1 diabetes mellitus, and those who were not enrolled in the Regional Medical Council at the time of the second stage of the study. </p>
      <p>In the first stage, the subjects were selected at predetermined dates that were scheduled with the school board. In the second stage, they were located through the Regional Medical Council of Goi&#225;s, and then contacted by telephone to schedule an interview for the collection of data. For those individuals who did not live in the metropolitan area of Goi&#226;nia, this data collection was conducted by telephone. The data referred to in these specific cases were considered for final analysis. All participants were informed about the study procedures in 1993 and signed a consent form, and the same procedure was repeated at the later stage.</p>
      <p>The questionnaire used in 1993 was applied again after 15 years, and the same variables were evaluated, namely: age; gender; diagnosis and previous treatment of hypertension; dyslipidemia; or diabetes. Individuals were also asked about the occurrence of major cardiovascular events (myocardial infarction - MIA, stroke, or coronary artery bypass grafting - CABG). </p>
      <p>As for lifestyle, we analyzed the history of smoking habit (smoker or nonsmoker), alcohol consumption (drinking alcohol or not), and physical activity (sedentary - no physical activity; irregular physical activity - less than 30 minutes a day 3 times/week; and regular physical activity - 30 minutes or more a day 3 times/week). The presence of an early cardiovascular disease in a first degree relative (&lt; 65 years for women and &lt; 55 years for men) was also taken into account.</p>
      <p>
        <bold>Objective measurements</bold>
      </p>
      <p>In the first and second stages, the following variables were assessed using the same methodologies of the study:</p>
      <p><italic>Weight - </italic>individuals wearing light clothing and without shoes; a Plenna Lithium electronic scale, with a maximum capacity of 150 kg and precision of 100 g was used.</p>
      <p><italic>Height - </italic>subjects without shoes; a SECCA laser stadiometer, model 206, with an accuracy of 0.1 cm was used.</p>
      <p><italic>Body mass index (BMI) - </italic>the formula established by Quetelet (BMI = weight in kg/height<sup>2</sup> in meters)<sup>14</sup> was used. Values of BMI <underline>&gt;</underline> 25 kg/m<sup>2</sup> were classified as overweight<sup>15</sup>. </p>
      <p><italic>Blood pressure (BP) - </italic>a semiautomatic OMRON HEM705 CP equipment was used. Measurements were taken in the right upper limb, after 5 minutes of rest, with the subject seated and the arm supported. Blood pressure was measured twice with a two-minute interval between them. For data analysis purposes the second blood pressure measurement was taken into account, and hypertension was defined by values greater than or equal to 140/90 mmHg<sup>16</sup>. </p>
      <p><italic>Waist circumference (WC) - </italic>measured only in the second stage of the study (at the midpoint between the last rib and the iliac crest, at the end of expiration), with a measuring tape graduated in centimeters. WC was considered increased if greater than 88 cm in women and 102 cm in men<sup>15</sup>.</p>
      <p>
        <bold>Data collected by telephone</bold>
      </p>
      <p>Data collection was conducted by telephone with 11 individuals. In these cases we used the reported weights and heights. The subjects were asked to measure their blood pressure, with a calibrated equipment used in their daily practice, and their waist circumference, following the recommendations provided in the study. As they were health professionals, there were no difficulties for the implementation of such procedures, and the data were considered reliable.</p>
      <p>
        <bold>Laboratory data</bold>
      </p>
      <p>In the first stage, after 12 hours of fasting, blood glucose and cholesterol levels were measured in a sample of blood taken by finger prick with a lancet, using the test strip method, with HEMOGLUCOTEST and REFLOTRON devices, respectively. </p>
      <p>For the second stage, we used fasting glucose and lipid profile tests conducted up to six months before the questionnaire was completed, provided that the samples were collected after 12 hours of fasting and the recommendation of not drinking alcohol for 48 h prior to the collection was followed. Only five subjects did not have the test results needed to fit those requirements, and new collections were taken for them. The method used for measurement of total cholesterol (TC), HDL cholesterol (HDL), triglycerides (TG), and plasma glucose levels was the colorimetric-enzymatic method for all subjects included in the analysis, even though the collections were not performed in the same laboratory. The value of LDL cholesterol was estimated by the Friedewald formula, in which LDL = TC - (HDL + TG/5)<sup>17</sup>.</p>
      <p>The subjects who had total cholesterol levels of 200 mg/dl or over were considered dyslipidemic. We decided not to use cholesterol and triglyceride fractions in this evaluation, because these data did not exist in the initial analysis of the sample, thereby precluding a comparison. </p>
      <p>Although the methodologies used to measure cholesterol and glucose values were not the same in the two stages of the study, this did not compromise the data analysis, because there is ample documentation in the literature regarding the correlation between values obtained by these methods<sup>18-21</sup>. </p>
      <p>
        <bold>Database and statistical analysis</bold>
      </p>
      <p>The data were stored in a database structured in the Excel program (Microsoft) and analyzed comparatively. The statistical analysis was performed using the SPSS software (Statistical Package of Social Science, version 15.0, Chicago, IL, USA). The Kolmogorov-Smirnov test was used to see whether the continuous variables presented normal distribution. The Student t test for paired samples was used to compare the numerical variables of the study, expressed as mean and standard deviation. The comparative analysis of CVRF in the period between 1993 and 2008 was performed using the chi-square test and the Fisher test. The analysis of correlation of the numerical variables between the two stages of the study was conducted by the Pearson correlation test. The significance level was set at p &lt; 0.05.</p>
      <p>
        <bold>Funding</bold>
      </p>
      <p>This study was partially funded with the Grant Aid of Research of the Brazilian Society of Cardiology (SBC).</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>The database of the first stage of the study consisted of 100 individuals, of which 74 (74.0%) were located for the second stage of the analysis after 15 years. We excluded two individuals, one for not agreeing to participate, and the other for having been diagnosed as having type 1 diabetes; the data of 72 physicians were used for data analysis. </p>
      <p>Of the 100 individuals studied in 1993, 39.0% were female, with a mean age of 19.9 years (minimum 18 and maximum 22 years). In the group studied in 2008, the average age was 34.8 years (minimum 33 and maximum 37), 37.5% of these being female. </p>
      <p>In the first stage of the study, none of the medical students reported having hypertension, dyslipidemia, or diabetes. In the second analysis, regarding hypertension awareness, an individual reported to be hypertensive and to be under treatment. Regarding dyslipidemia, this number was higher, as 6 subjects reported having lipid profile abnormalities, and only three (50%) were under treatment (pharmacological or not). There was no reference to type 2 diabetes awareness. </p>
      <p>No early cardiovascular event was reported in first degree relatives in 1993, whereas 15 individuals reported such events in 2008. </p>
      <p>No cardiovascular event occurred in the group evaluated after 15 years of evolution. </p>
      <p>In the analysis of the prevalence of cardiovascular risk factors in the population studied in the period of 1993-2008, there was a significant increase in hypertension, overweight, and dyslipidemia. For other CVRF (sedentary lifestyle, smoking habit, and alcohol consumption), the changes were not significant (<xref ref-type="table" rid="tab1-body3">Table 1</xref>). </p>
      <table-wrap id="tab1-body3">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt01-en.jpg"/></table-wrap>
      <p>The comparison between systolic blood pressure (SBP), diastolic blood pressure (DBP), blood glucose and cholesterol values in the two stages showed elevated mean values with significant differences in all variables (<xref ref-type="table" rid="tab2-body3">Table 2</xref>). </p>
      <table-wrap id="tab2-body3">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt02-en.jpg"/></table-wrap>
      <p>In evaluating the same variables by gender, we found that in males there was a significant increase in all variables (systolic and diastolic blood pressures, BMI, blood glucose, and cholesterol), whereas in females there was only a significant increase in BMI, blood glucose, and cholesterol (<xref ref-type="table" rid="tab3-body3">Tables 3</xref> and <xref ref-type="table" rid="tab4-body3">4</xref>). </p>
      <table-wrap id="tab3-body3">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt03-en.jpg"/></table-wrap>
      <table-wrap id="tab4-body3">
        <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gt04-en.jpg"/></table-wrap>
      <p>There was no difference in the prevalence of CVRFs, when each gender was evaluated separately, except for overweight. Regarding this variable, among men, we found 6 (13.33%) individuals with BMI <underline>&gt;</underline> 25 kg/m<sup>2</sup> in 1993, whereas in 2008, we found 14 (31.1%) young subjects with this classification of BMI (p &lt; 0.001). </p>
      <p>In the correlation analysis between the values obtained in 1993 and 2008, we found a positive correlation between systolic blood pressure, diastolic blood pressure, glucose, and BMI (p &lt; 0.001). For cholesterol, no such correlation was demonstrated (r = 0.186, p = 0.117;) (<xref ref-type="fig" rid="en_aop08210a03fig01m-body3">Figure 1</xref>). </p>
      <p content-type="asset">
        <fig id="en_aop08210a03fig01m-body3">
          <graphic xlink:href="1678-4170-abc-95-03-0332-00084-gf01-en.jpg"/></fig>
      </p>
      <p>Waist circumference was measured only in the second stage of the study, thus making comparison impossible. We found 9 (12.5%) individuals with increased WC, three women and six men.</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>This study showed a significant increase in the prevalence of some cardiovascular risk factors (overweight, dyslipidemia, and hypertension) in this population. These findings were not repeated for the other cardiovascular risk factors analyzed. Smoking habit, physical inactivity, and alcohol consumption were behavioral aspects that did not change significantly over the study period. </p>
      <p>The increasing prevalence of overweight over time has already been reported by some Brazilian studies, including the Ciorlia and Lotufo studies, which analized the evolution of BMI in specific populations<sup>9,22</sup>. Moreover, the obesity epidemic is a reality in developed countries, and has also been observed in developing countries<sup>23,24</sup>. Our study group, although distinguished by their formal education in health, did not show a different pattern. However, the prevalence of overweight in this group was lower in the two stages of the study, when compared with that of the same age population of the capital cities of Brazil<sup>25</sup>. </p>
      <p>The prevalence of dyslipidemia, even though it rose significantly during the study, was much lower than that described in the literature produced in Brazil, in both stages of the study. Studies conducted in the population of nine capitals, with a mean age of 35.4 years - in this respect quite similar to the population of the second stage of our analysis - revealed a 38.0% prevalence of total cholesterol <underline>&gt;</underline> 200 mg/dl for males, and 42.0% for females<sup>26</sup>. Our data showed only 19.4% for both genders. </p>
      <p>When comparing the number of hypertensive individuals in both stages of our study with that of the population of Goi&#226;nia<sup>27</sup> divided by age group, we found lower rates of hypertension in our group, in both stages, despite the detection of an increased prevalence of hypertension over the 15-year period. This information corroborates the existance of a relationship between hypertension and low levels of schooling, since our study population was composed, at the first stage, by students, and at the second stage, by professionals with a college degree and who, therefore, had a higher degree of instruction when compared to the general population of Goi&#226;nia. </p>
      <p>Our study showed that even for the cardiovascular risk factors whose prevalence increased significantly over the 15-year follow-up, these prevalence rates were lower than in the general population. These data are superimposable to those found in the Physicians Health Study<sup>28</sup>, which demonstrated that the prevalence of cardiovascular risk factors was substantially lower among American physicians when compared to that of the general population. </p>
      <p>A household survey data from the Ministry of Health revealed that the prevalence of smoking habit ranged from 12.9 to 25.2%, depending on the city analyzed, with an increase in prevalence in individuals with lower education and older age<sup>25</sup>. Taking into account the prevalence of 1.0% and 5.6% in the two stages of our research, we concluded that the health professionals analyzed in this study smoked less than the general population, following the same pattern of age distribution of the population of the Brazilian capital cities. </p>
      <p>In the group investigated, sedentary lifestyle was identified in 35.0% of the subjects in the first stage, and in 27.8% of the subjects in the second, but this reduction was not statistically significant. In the population of nine Brazilian capitals, this risk factor for cardiovascular disease ranged from 28.2% to 54.5%. However, differing from our findings, the population tended to be most active between 15-24 years. Another interesting finding was the absence of the influence of the education level on the prevalence of physical inactivity;<sup>25</sup> these data confirm our findings.Alcohol consumption did not change significantly, and its prevalence in the two stages of our study was similar to that found in the population of Brazilian capital cities. We should point out that the trend of increasing alcohol consumption with increasing age and education level<sup>25</sup> was not observed in our study. </p>
      <p>Separating the prevalence of risk factors by gender, we found differences only in overweight, which was higher in males. All the other CVRF, when analyzed by gender, did not change over the years. This fact suggests that in this group of individuals, the evolution of these prevalences occur homogenously in both genders, except for overweight. However, the sample was not large enough to safely demonstrate differences in the evolution between genders. </p>
      <p>In the numerical analysis of the levels of blood pressure, cholesterol, glucose, and BMI, we found a significant elevation in all of these variables over the 15-year period, perhaps due to the population aging. Observing these same variables by gender, we detected a significant increase in BMI, blood glucose, and cholesterol in both genders, whereas the increase in blood pressure (systolic and diastolic) was only significant in males. </p>
      <p>In the study of the correlation between values obtained in 1993 and in 2008, we found a significant positive correlation between DBP, SBP, blood glucose, and BMI, i.e. the same individuals who had higher levels in 1993 also had higher levels in 2008. However, cholesterol values were not correlated between the two stages of the study. On further analysis of these data, we observed higher correlations (greater r values) for systolic blood pressure and body mass index. This suggests that monitoring and a more aggressive approach to the control of these variables could have great impact as health promoting measures, although <italic>p</italic> values have shown significant results in the comparison of all variables considered above. </p>
      <p>As already suggested by Monego &amp; Garden, when studying the determinants of cardiovascular disease risk in school-aged population<sup>29</sup>, these data can be used in strategies for early intervention on modifiable risk factors. </p>
      <p>Some limitations of our study should be mentioned. One of them was the fact that not all individuals evaluated in 1993 were located in 2008. This is explained by the long interval between the two data collections, and by the fact that no contact was maintained with these research subjects in this period. Nonetheless, the revaluation of more than 70% of the initial group of individuals makes the sample representative and allows for the conclusions drawn.</p>
      <p>The glucose and lipid profile samples in the second evaluation should also be mentioned. These samples were obtained in different laboratories, and for some of the physicians (11 subjects, 15.27% of the sample in the second evaluation), the results were obtained by telephone. It is noteworthy that the methodology used in the analysis of biochemical variables was the same (colorimetric-enzymatic method), regardless of the fact that the laboratories were not the same and that the collection had been carried out by telephone. We also emphasize the quality of the information obtained by telephone, inasmuch as the subjects were medical professionals.</p>
      <p>Another limitation to be noted was the use of different methodologies for the analysis of cholesterol and glucose levels in the two stages of the study. Although the methodologies were not the same, there is ample documentation in the literature that confirms the correlation between values obtained by such methods, without compromising the data analysis<sup>18-21</sup>. Furthermore, the lipid profile and serum glucose analysis expands the possibilities for future approaches in this population with regard to these factors, which are important determinants of cardiovascular risk. </p>
      <p>
        <bold>Conclusions</bold>
      </p>
      <p>In a cohort of medical professionals, there was an increase in SBP, DBP, glucose, BMI, and cholesterol levels in 15 years of evolution. In the analysis of the prevalence of cardiovascular risk factors, we observed an increased prevalence of hypertension, overweight, and dyslipidemia. </p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was partially funded by <italic>Bolsa de aux&#237;lio &#224; Pesquisa da Sociedade Brasileira de Cardiologia</italic>.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Thiago de Souza Veiga Jardim, from <italic>Universidade Federal de Goi&#225;s</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
